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ABSTRACT
This study investigated a potential mechanism of action underlying the anticancer 
activity of conjugated lmoleic acid (CLA), referring to a mixture of positional and 
geometric conjugated isomers of lmoleic acid Ras, an oncogene necessary for normal 
cell function, when mutated results m uncontrolled cell proliferation and consequently 
tumour formation Western blot analysis suggested that c9, i l l  and flO, cl2 CLA 
isomers inhibit (P<0 05) expression and activation of mutated ras compared with ethanol 
control in SW480 cells, a numan colon cancer cell line Lmoleic acid stimulated cell 
growth, however it reduced ras expression, suggestmg that events downstream of ras 
may be more critical targets for modulating growth by these fatty acids A second 
objective was to investigate the cytotoxic effect of CLA-rich oils produced by the 
fermentation of lmoleic acid by selected CLA-producmg strains Lmoleic acid-nch oil 
fermented by B breve NCFB 2258 reduced growth of SW480 cells in a time dependant 
manner at a concentration of 84 \ig fat/ml This oil contained 20 \ig c9, t\ 1 CLA/ml 
When pure fatty acids were combmed to mimic the fatty acid profiles of the microbially 
fermented oils, the growth inhibitory effect observed was only partly attributable to the 
CLA content of the oil This study also examined a nutritional approach to the 
enrichment of CLA m milk fat by dietary supplementation of pre-selected cows on 
pasture with full fat rapeseeds Surprisingly, there was no significant effect on milk fat 
c9, /II CLA due to rapeseed supplementation In addition, elaidic acid, a fatty acid not 
previously demonstrated to be influenced by rapeseed supplementation, increased 
significantly in the milk of cows on the supplemented diet These unexpected results 
may be attributed to excessive ramfall throughout the period of the trial affecting pasture 
quality and possibly an altered biohydrogenation process
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CHAPTER 1
I N T R O D U C T I O N
1.1 Conjugated Linoleic Acid (CLA)
Conjugated linoleic acid (CLA) is a mixture of positional and geometric isomers of 
linoleic acid, C l8:2 (LA).
Linoleic acid has double bonds at positions 9 and 12 (Figure 1.1). CLA differs from 
LA in that the double bonds are conjugated and not separated by a methylene group. 
Therefore, there are a number of possible positions for the double bond i.e. C positions 
8 and 10, 9 and 11, 10 and 12 and 11 and 13. Table 1.1 presents the primary sources of 
CLA in the human diet. CLA is found in the lipid fraction of milk, dairy products and 
the meat of ruminants (Lin, et al., 1995). Dairy products are the major source of CLA 
with the c9, t \ \  CLA isomer accounting for 80-90% of total CLA in dairy products 
(Chin, et al., 1992).
Data regarding the dietary intake of CLA in humans is limited. However, it has been 
estimated that human intake of CLA is below the levels required for optimal 
physiological benefits (McGuire, et al, 1999; Santora, et al., 2000; Ritzenthaler, et al., 
1998).
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Table 11  Dietary sources of CL A (from Roche, et a l , 2001)
Source CLA Content (g/lOOg fat)
Whole milk 0 55
Low fat milk (2%) 0 41
Condensed milk 0 70
Butter 0 47
Plain yoghurt 0 48
Low fat yoghurt 0 44
Frozen yoghurt 0 28
Cheddar cheese 0 41
Processed cheese 0 50
Beef (uncooked) 0 43
Lamb (uncooked) 0 58
Veal (uncooked) 0 27
Consumption of diets rich in CLA has been shown to enrich blood and tissue CLA m 
humans (Huang, et a l , 1994, Jiang, et a l , 1999) In addition, humans have been shown 
to be capable of synthesising CLA m the body (Salmmen, et a l, 1998j Fntsche and 
Steinhart, (1998) reported a daily intake of 0 5 to 1 5 g of CLA in the human diet 
However, a Swedish study reported an average daily CLA intake of 0 16 g (Jiang, et 
a l , 1999) This study also suggested that CLA intake today is lower than that m the 
1960s, most probably due to the reduced consumption of animal fat in the diet 
compared to the 1960s
1.2 Analysis of CLA
Trans fatty acids (TFAs) can be analysed using varying techniques such as infrared 
spectroscopy (IR), gas chromatography (GC), silver-ion (Ag+) chromatography, gas 
chromatograpgy-Fowrzer transform infrared spectrospectory (GC-FTIR) and gas 
chromatography-mass spectroscopy (GC-MS) (reviewed m Fntsche and Stemhart,
1998)
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In the analysis of CLA it is important that the different isomers are separated This is 
typically done by GC Unlike industrially synthesised CLA, naturally produced CLA is 
present at very low levels and in estenfied form in foodstuffs making analysis of 
natural CLA more difficult
GC separates components of a volatile sample To use GC, a sample must be in a 
volatile state Therefore, lipids must undergo trans-estenfication to form fatty acid 
methyl esters (FAMEs) To produce FAMEs, acid- or base-catalysed methylation of 
the sample must first be earned out CLA is present as both free and estenfied faity 
acids in foodstuffs In addition, the quantity and type of isomers present vanes from 
one food to another Acid catalysed methylation is used to prepare both free fatty acids 
and estenfied fatty acids for GC analysis Typical catalysts for this reaction are 
HSC^/methanol, anhydrous HCl/methanol or BF3/methanol Earlier fornis of this 
method led to the formation of excessive amounts of trans/trans CLA isomers and/or 
allylmethoxy denvatives (AMD) (Yurawecz, et a l, 1999) This problem was 
overcome by reducing the temperature and methylation time to 60°C for 20 minutes 
using 4% methanolic HC1 or 14% BF3/methanol at room temperature for a longer time 
penod (Kramer, et a l , 1997, Yurawecz, et a l , 1999) However, any CLA estenfied in 
triglycende or phosopholipid may not undergo full methylation Using compounds 
such as tetramethylguanidine (TMG) or NaOCH3 (Shantha, et a l , 1993) as catalysts to 
methylate estenfied CLA can overcome this problem However, these catalysts are not 
suitable for free CLA Base catalysed methylation denvatises estenfied fatty acids 
only One of the most popular catalysts for this reaction is 0 5N sodium methoxide in 
anhydrous methanol, although in some cases potassium methoxide or hydroxide can be 
used in place of sodium methoxide (reviewed in Chnstie, 2001)
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Park, et al (2002) studied the optimum méthylation conditions required by a number 
of CLA samples (Table 1 2)
Table 1.2 Example of optimum méthylation conditions (Park, e ta l, 2002)
Sample Méthylation
Agent
Temperature (°C) Time (mins)
Free CLA 10N H 2S04 55 5
CLA estenfied m 20% TMG 100 5
safflower oil
CLA estenfied in 20% TMG 100 10
phospholipid AND
10N H 2S04 55 5
CLA estenfied m egg Base hydrolysis
yolk lipid AND
IO N H 2SO4 55 5
In general Carbowax capillary columns are used in GC analysis of fatty acids Long 
retention times are associated with GC analysis of CLA as long columns are required 
for adequate separation Despite the mam CLA isomers (c9, i l l  and ¿10, c\2) being 
well separated on this type of column, they are not separated from other positional 
CLA isomers For example, c9, i l l  and c 8 ,110 CLA overlap The isomers elute in the 
order cis/trans, cis/cis, and trans/trans (Christie, 2001) However, it is still possible to 
quantify total CLA content
In foodstuffs other fatty acids such as C21 0 and C20 2 elute in the same region as the 
cis/cis, and trans/trans CLA isomers In such instances it is beneficial to use GC-MS 
for analysis The advantage of this system is that it is possible to identify the presence 
of non-conjugated double bonds and to locate the double bonds
Thin layer chromatography (TLC) poses the problem of elution of conjugated dienes 
with monoenes Therefore, it is more beneficial to use silver ion high performance 
liquid chromatography (Ag+ HPLC) A method devised by Adlof and Lamm (1998) 
has since been improved upon (reviewed in Yurawecz, et a l , 1999) In this instance 
hexane is used as the mobile phase containing a small quantity of acetomtnle, with an 
ultraviolet detector at 234 nm Remarkable separation can be achieved by using six 
columns in series This method can also be used to analyse free CLA without the need 
to methylate prior to analysis (Cross, et a l , 2000)
Figure 1 2 Separation of CLA isomers using a single Ag+ HPLC column (Sehat, et a l , 1998)
Figure 1.2 shows the separation of CLA isomers achieved by using a single Ag+ 
HPLC column whereas Figure 1 3 shows the separation of CLA isomers achieved 
with Ag+ HPLC columns m series
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Figure 1 3 Separation of CLA isomers using Ag+ columns in series (Kramer, et a! , 1999)
With Ag+ chromatography, it is also possible to analyse CLA in the form of p- 
methoxyphenacyl esters using a mobile phase which consists of
dichloromethane/hexane/acetomtnle (Nikolova-Damyanova, et at, 2000) All fatty 
acids present can be detected via the p-methoxyphenacyl moiety
As CLA is often present in foodstuffs at very low concentrations it is sometimes 
necessary to concentrate the CLA prior to quantification This is usually earned out via 
reverse-phase chromatography or Ag+ chromatography, although better results are 
achieved when these methods are used m senes Reverse-phase chromatography can 
be used to obtain a C l8 fraction This fraction is then applied to the reverse-phase Ag+ 
HPLC column resulting in a fraction ennched m CLA (reviewed m Chnstie, 2001)
As individual CLA isomers have been associated with different health benefits, 
accurate quantification is necessary It is clear that CLA is sensitive to methylation 
conditions, stressing the importance of the optimum conditions of analysis
A variety of health benefits have been attributed to CLA However, the majority of 
these health benefits have been observed m animal models Therefore, it is not certain 
if CLA would benefit humans in the same way or to the same extent CLA has been 
associated with a number of health benefits including an anti-carcinogenic effect, an 
anti-atherosclerotic effect, improvements in bone metabolism, an anti-thromobotic 
effect, a reduction in body fat, enhancement of immune function and improvements in 
diabetes status (reviewed in Belury, 2002) This study focuses on the anticarcmogemc 
effects of CLA and this particular health benefit is discussed in detail below
1 4 Effect of CLA on Carcinogenesis
The anticancer effect of CLA is probably the most studied health benefit associated 
with the fatty acid During a study of the formation of mutagenic compounds during 
cooking it was discovered that fried ground beef possessed anticarcmogemc properties 
(Pariza et a l, 1979) In 1983, Panza, et al isolated the component responsible for the 
antimutagemc effect and named it a mutagenesis modulator It was m 1987 that this 
compound was identified as a mixture of four CLA isomers -  c9,tll, (9,t i l ,  tlQ,cl2 
and ¿10/12 CLA (Ha, et a l , 1987) Compared with LA, which has been implicated 
with the incidence of prostate and colon carcinogenesis in humans (Enckson, 1998, 
Zock and Katan, 1998), it has now been demonstrated that CLA has an ability to 
antagonise mammary cancer (Ip, et a l, 1991, Durgam and Fernandes, 1997, 
Cunningham, et a l , 1997, Ip and Scimeca, 1997), stomach cancer (Ha, et a l , 1990), 
skin cancer (Belury, et a l , 1996) and prostate cancer (Cesano, et a l , 1998) It has been 
demonstrated that CLA can inhibit cancer initiation (Ha, et a l , 1987, Liew, et a l , 
1995), promotion (Ip, et a l, 1994a, 1996) and, progression and metastasis (Cesano, et
1 3 Health Benefits Associated with CLA
al , 1998) Visonneau, et al (1997) attnbuted an anti-mutagemc effect when the spread 
of cancer cells to lungs, peripheral blood and bone marrow in SCID (severe combined 
lmmuno-deficiency) mice was prevented The ability of CLA to inhibit angiogenesis 
may contribute to its efficiency as an anti-metastatic agent (Masso-Welch, et a l , 
2002)
Data suggest that there is a concentration at which CLA optimally inhibits 
carcinogenesis In one particular study it was observed that a concentration of 1% CLA 
reduced the incidence of mammary tumours, however increasing the concentration did 
not further reduce tumour incidence (Ip, et a l , 1991) It has been demonstrated that 
better results are obtained when CLA is administered pnor to tumour initiation (Ip, et 
a l ,1995)
It is of interest that the majority of the studies regarding the anticarcinogemc activity 
of CLA have involved the use of free CLA isomers Ip, et al (1999) found that butter 
rich in CLA and free CLA were effective m reducing terminal end buds (TEBs) to a 
similar extent TEBs are the primary site for mammary carcinogenesis induction m 
both rat and human mammary cancer Ip, et al (2001) demonstrated that c9, t\ 1 CLA 
m a triglyceride was as effective as free c9, ¿11 CLA in controlling rat mammary 
epithelium proliferation The anticancer activity of CLA has been demonstrated despite 
the type or level of dietary fat present (Ip, et a l, 1996, Ip and Scimeca, 1997) Ip, et al 
(1996) compared the anticancer effect of 1% CLA in a diet rich m com oil compared 
to the same treatment m a diet nch in lard Although the com oil and lard differed 
greatly in their hnoleate content, the anticancer effect of CLA was independent of the 
type of fat present Linoleate is a precursor of arachadomc acid (AA) and in turn
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eicosanoids A positive relationship between derivatives of eicosanoids and cell 
proliferation and inflammation in mammary, colon and skm tumours has been reported 
(Belury, 1995) Unlike CLA, LA has been shown to stimulate the development of 
tumours (Cesano, et al , 1998, Ip, et al ,1985)
Differences in species are of great importance when extrapolating rodent data to 
humans For example, CLA has been linked with an increase in the development of 
hepatic cancer in a specific mouse model due to an ability to enhance peroxisome 
proliferation (Beluiy, et a l , 1997, Kouseknecht, et a l , 1998) Enhanced peroxisome 
proliferation has been associated with development of hepatocarcmogenesis (Kraupp, 
et a l , 1990) However, CLA did not induce hepatic peroxisome proliferation in 
Sprague-Dawley rats (Moya-Camarena, et a l , 1999a)
Data relating to the effect of CLA m humans is limited, but one of the more promising 
results comes from a study which demonstrated that there was an inverse relationship 
between the level of CLA in the mammary tissue and the risk of breast cancer 
(Bougnoux, et a l , 1999) Both dietary CLA and serum CLA were reported to be lower 
m Finnish breast cancer patients than m control subjects (Aro, et a l , 2000) However, 
a recent epidemiological study showed no relationship between breast cancer nsk and 
CLA intake (Voorrips, et a l , 2002) while CLA content in breast adipose tissue m a 
population of French patients was not associated with relative nsk of breast cancer 
(Chajes, et a l , 2002) It is therefore not yet certain if  the suggested anticarcmogenic 
property of CLA in annual and tissue culture models can benefit humans
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Despite the abundance of evidence suggesting that CLA inhibits tumour progression, 
its mechanism of action is not so clearly established Due to the differential effects of 
CLA isomers it is possible that anticarcinogemc activity may be the result of a number 
of biochemical mechanisms It may be possible that the combined effect of different 
CLA isomers leads to the anticarcinogemc property of CLA, however individual 
isomers have been shown to possess anticarcinogemc ability (O’Shea, 2000) 
Schonberg and Krokan (1995) demonstrated that the anticancer affect of CLA was 
specific to a number of cell lines Therefore, it is clear that differing experimental 
conditions regarding the CLA isomers analysed or experimental model used can lead 
to varying results
Initially it was believed that the anticarcinogemc activity of CLA was due to an 
antioxidant property Studies by Ha, et al (1990), Ip, et al (1991, 1996) and Pariza, et 
al (1991) have all suggested this However this evidence is not explicit Such studies 
have involved experimental conditions which do not replicate biological systems (Ha, 
et a l , 1990) or used measurements of oxidative damage which are indirect and not 
specific (Ip, et a l , 1991) In contrast, a study by van den Berg, et a l , (1995) 
demonstrated that CLA was not an effective antioxidant, having only a slight effect 
after 1 hr of oxidative stress In addition, CLA was found to interfere with the 
metabolism of a-tocopherol (a potent antioxidant) (Nicolosi, et a l , 1997) CLA has 
been shown to induce lipid peroxidation in the MCF-7 human breast cancer cell line 
(O’Shea, et a l , 1999) The data suggested that accumulation of lipid peroxidation 
products such as conjugated diene hydroperoxides may lead to internal cellular pro- 
oxidation However, Wong, et al (1997) found that CLA did not increase lipid
1 5 Anticancer Mechanisms of CLA
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peroxidation in mice with transplanted metastatic munne mammary tumours The 
difference between these two studies may be due to species differences Elevated 
levels of 8-iso-PGF2a (a biomarker of non-enzymatic lipid peroxidation) and 15-keto- 
dihydro-PGF2a (a biomarker of enzymatic lipid peroxidation) in the unne and plasma 
of humans after administration of CLA have been demonstrated by Basu, et al (2000) 
Similar results were observed by Miller, et al (2001) in human breast and colon cancer 
cell lines
Another possibility is the interference of CLA m the pro-oxidant/antioxidant balance 
via interference with the expression of antioxidant defense enzymes This was 
demonstrated in studies by O’Shea, et al (1999) and O’Shea, et al (2000), in which 
the activity of three such enzymes was increased after CLA treatment The presence of 
CLA may lead to enhanced oxidative stress due to its conjugated double bonds 
(Belury, 1995) resulting m increased levels of these enzymes It is widely accepted that 
peroxides and superoxides generated from lipid peroxidation damage DNA and other 
cellular functions m pathological conditions Hawkins, et a l , (1998) demonstrated that 
the incidence of apoptotic cells m leukaemia and pancreatic cells treated with 
polyunsaturated fatty acids (PUFAs) was correlated with the degree of lipid 
peroxidation mduced by PUFAs and the number of double bonds present in the 
PUFAs Further analysis involving vitamin E, an antioxidant, demonstrated that 
apoptosis mduced by PUFAs was oxidative (Tyurina, et a l , 2000)
Prostaglandins are derived from AA metabolism and fall under the category of 
eicosanoids along with leukotnenes and thromboxanes Figure 1 4 shows the pathway 
involved in the synthesis of eicosanoids and the implications involved with the
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presence of prostaglandins in the body. Li and Watkins (1998) have shown that CL A 
affects prostaglandin synthesis.
Dietary or Endogenous Sources of Arachidonate
Membrane Phospholipids
Dietary OR Endogenous Sources for 
Linoleate OR CLA
/ A6 Desaturase/Elongase/ A5 
/  Desaturase
Arachidonate (C20:4) OR Conjugated Arachidonate (C20:4)
Cyclooxygenases Lipoxygenase
Prostaglandins, Thromboxanes Hydroxyeicosatetraenoates (HETEs)
inflammation, Vascularization, 
Tumour Promotion
Leukotrienes
Events in Immune Response and 
Inflammation
Figure 1.4 Pathway of eicosanoid synthesis from arachidonate (taken from Belury, 2002)
CLA also interferes with prostaglandin metabolism (Liew, et al., 1995; Pariza, et al.,
1999) and has been shown to reduce AA production in mice (Banni, et al., 1999; 
Belury and Kempa-Steczko, 1997). CLA was found to displace AA and LA in 
membrane phospholipids (Belury and Kempo-Steczko, 1997; Liu and Belury, 1998; 
Banni, et al., 1999; O’Shea, et al., 2000); therefore it may be possible that this 
displacement due to CLA may interfere with eicosanoid synthesis and other signalling 
pathways. Prostaglandin E2 (PGE2), leukotriene B4 (LTB4) and 5-hydroxy- 
eicosatetraenoic acid have been associated with the stimulation of both prostate and 
colon tumour proliferation (Qiao, et al., 1995; Bortuzo, et al., 1996; Ghosh and Myers,
1998). AA is formed due to the desaturation of LA. It has been suggested that if CLA 
competes for desaturation with LA the result would be a reduction in the synthesis of
13
eicosanoids and in turn a reduction m eicosanoid stimulation of cancer cell 
proliferation (Belury, 1995, Parodi, 1997, Liu and Belury, 1998, Banni, et a l , 1999) 
A study by Miller, et al (2001) demonstrated that the c9, i l l  CLA isomer reduced 
uptake of AA into phosphotidylcholine (PC) m MCF-7 breast cancer cells PC is the 
phospholipid which is preferentially hydrolysed to synthesise eicosanoids (Hanel, et 
a/,1993)
It has been suggested that CLA may act as a ligand for nuclear hormone receptors, 
peroxisome prohferator-activated receptors (PPARs) (Khewer, et a l , 1997, Moya- 
Camarena, et a l , 1999b, Vanden Heuvel, 1999) PPARs are responsible for activation 
of genes involved in the regulation of lipid and carbohydrate metabolism PPAR-a and 
y are known to be expressed in cancer cells and CLA has been found to be a ligand for 
these two isoforms of PPARs (Khewer, et a l , 1997, Moya-Camarena, et a l , 1999b) 
Activation of PPAR-y in human prostate and colon cells results in growth arrest and 
the induction of cellular differentiation (Sarraf, et a l , 1998, Kitamura, et a l , 1999, 
Mueller, et a l , 2000) Despite both c9, i l l  and ilO, cl2  CLA possessing an ability to 
activate PPAR-a (Moya-Camarena, et a l , 1999b), this isoform does not induce 
differentiation in human colon cancer (Sarraf, et a l , 1998)
Apoptosis (programmed cell death) due to oxidative stress has been shown to involve 
the oxidation of membrane phospholipids as part of a final common pathway 
(Fabisiak, et a l , 1998) Palombo, et al (2002) reported an increase in caspase activity 
due to treatment of MIP-101 (colorectal cancer) and PC-3 (prostate cancer) cells with 
100 pM ilO, cl2  CLA, indicative of the induction of apoptosis by this CLA isomer Ip,
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et al (2000) demonstrated that a mixture of CLA isomers led to induction of apoptosis 
m mammary cancer cells via downregulation of bcl-2, a membrane protein
Ip, et a l , (2001) found that CLA suppression of mammary epithelium proliferation 
was partly due to a decrease in components (cyclm D1 and cychn A), which play 
important roles m the cell cycle Combined with the data from Ip, et al (1999) a theory 
for CLA’s anticancer activity in mammary carcinogenesis has been suggested 
administration of CLA during pubesence suppresses cyclm expression Reduced cyclm 
levels results in a decrease in proliferation of TEBs and in turn a reduction in ductal 
branching of the mammaiy tree Reduced ductal branching decreases susceptibility to 
mammaiy carcinogenesis
Another possibility is that CLA may interfere with cell signalling via inhibition of ras, 
an oncogene which regulates cell proliferation -  however when mutated, ras can lead 
to uncontrolled cellular proliferation and cancer development (discussed in Chapter 
2) Data regarding the effect of CLA on ras is lnnited Ip, et al (1997) suggested that 
the inhibitory effect of CLA on mammary cancer development is independent of the 
presence or absence of the ras gene However, O’Shea (2000) demonstrated that when 
incubated with human colon cancer cells, CLA inhibited the activity of protein 
famesyltransferase (PFTase) -  an enzyme necessary for the activation of ras The 
reaction between PFTase and ras leads to localisation of ras to the plasma membrane 
Ras must be bound to the membrane to be in its active state, therefore inhibition of 
membrane bound mutated ras renders it inactive and prevents undesirable cell 
proliferation Davidson, et al (1999) demonstrated that PUFAs inhibited membrane
association of colonic ras m rats without affecting famesylation (the reaction between 
ras and PFTase) Singh, et al (1997a) found that a diet high in corn oil promoted colon 
carcinogenesis m male F344 rats with a concomitant increase in ras expression, 
whereas a diet high in fish oil reduced colon carcinogenesis, m addition to a reduction 
in membrane-bound ras These data suggest that it may be possible that CLA interferes 
with ras signalling, however much study is required in this area due to the complexities 
involved as suggested by the varying results discussed above and the many factors 
involved in ras signalling (discussed in Chapter 2)
1.6 Objectives of the Study
Due to the many health benefits associated with CLA the objective of this study was to 
investigate methods resulting m the availability of enhanced levels of CLA in the 
human diet The first objective of this study was to investigate one possible anticancer 
mechamsm of CLA -  interference with ras expression The second objective was to 
investigate the ability of two probiotic strains of Bifidobacterium to produce CLA and 
to analyse the anticancer activity of the CLA produced The third objective was to 
enhance milk fat CLA via selection of high CLA-producing cows and dietary 
supplementation with rapeseed
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CHAPTER 2
C L A  I S O M E R S  I N H I B I T  R A S  
E X P R E S S I O N  I N  S W 4 8 0  C E L L S
2.1 Introduction
2.1.1 Cancer
Cancer growth can be the result of a mutation in genes, which promote cellular 
proliferation, or a mutation in genes which suppress cell division. Uncontrolled cell 
proliferation or inadequate suppression of cell division leads to formation of a tumour.
Programmed Cell
. Death (Apoptosis)
Conventional Therapeutics e.g. chemotherapy, radiation, gene therapy
Figure 2.1 Development of cancer cells
If a mutated cell is not repaired by the body’s DNA repair system or eliminated via apoptosis, a 
cancer cell develops.
Figure 2.1 summarises the development of cancer cells. Irreversible damage of DNA 
leads to the formation of a cell containing mutated DNA which can multiply to form 
additional mutated cells. Under normal conditions DNA repair may revert the cell back to 
a normal cell. Another possibility is the occurrence of apoptosis or programmed cell death.
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Apoptosis is a normal cellular process that involves eliminating unwanted or useless cells 
Without DNA repair or apoptosis, malignant growth of the cancer cell takes place with the 
possibility of metastasis (spread) of the cancer to other parts of the body Research is 
ongoing to find new and better methods of cancer treatment At present such methods 
mclude chemotherapy, radiation and gene therapy There are three stages of cancer 
initiation, promotion and progression Initiation occurs due to the presence of a chemical, 
biological or physical agent The promotion stage is not as well understood, but involves 
the mteraction of promoters with cell receptors Tumour progression is the result of 
molecular genetic mechanisms such as chromosomal rearrangement or further mutations
2 12 Cancer and Oncogenes
Oncogenes are genes which, when mutated, deleted, or abnormally expressed can cause 
growth of cancer cells When normally expressed these genes play an important role in 
normal physiological activities and are known as protooncogenes One example of a 
protooncogene is the ras gene Ras is the collective term for the three mammalian ras 
genes H-ras, K-ras (K-ras4A and K-ras4B) and N-ras This gene is necessary for the 
regulation of cell proliferation and differentiation as it encodes a monomeric guanine 
triphosphate (GTP) binding protem that is involved in signal transduction Mutations m 
the dominant oncogene ras represent the most commonly found gene mutations in human 
cancer cells The most common mutations of this gene occur at codons gly-12, gly-13 or 
gln-61 giving the gene the ability to morphologically transform established cells in 
culture These mutations all lead to the same defect m ras (described m Section 2 15) 
The ras mutation has been detected m 15% of all human tumours and is most commonly
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found in tumours of the colon (50%) and pancreas (90%) (reviewed m Bos, 1989) The 
high frequency of this mutation m human cancers is witness to the central role played by 
ras-encoded proteins m membrane-to-nucleus signal transduction (Ames, et a l , 1995)
2 1 3 Ras
Ras is an oncoprotein required for a variety of signal transduction pathways involved in 
cellular proliferation and differentiation More than 50 low molecular weight protems 
categonsed into the Ras-related superfamily act positively to stimulate a cascade of 
kmase-dnven phosphorylation events that culminate in the activation of nuclear 
transcription (Ames, et a l , 1995) Because of its central role in membrane-to-nucleus 
signal transduction, it has been proposed that modulation of the Ras superfamily of 
protems may provide a novel means by which growth of cancer cells can be inhibited 
(Gibbs, et a l , 1994)
Ras begins as a cytosolic precursor, which after post-translational modification, localises 
to the plasma membrane Famesylation of ras protems by PFTase is an essential step for 
their binding to the inner leaflet of plasma membranes and for activation of ras (Der and 
Cox, 1991) and downstream effectors leading to cell proliferation (reviewed in Adjei,
2001)
2 14 Post-Translational Modification of Ras
Post-translational modification mvolves the attachment of a famesyl or geranylgeranyl 
group (Figure 2 2) to the carboxy terminal cysteme residue (Goldstein and Brown, 1990)
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The substrate for the reaction is famesyl pyrophosphate (FPP) from which a famesyl 
group is cleaved and transferred to the carboxyl end o f the target protein e.g. ras by 
PFTase. The enzyme is specific for a CAAX sequence where C = cysteine, A = an 
aliphatic amino acid e.g. leucine, isoleucine or valine and X = methionine, serine or 
leucine. In K-ras, X is usually methionine while in H-ras X is usually serine (reviewed in 
Eskens, e t  a l . ,  2 0 0 0 ) .
R R R R R R R R S
Cell Membrane
7 T T 7 T T 7 T 7 7 T 7 T T 7 7 7 7 .......................................    . . . . .  . . . . . . . .  . . . .
O O O O O O O O O O O O O O O O O O O O O O O O O O O O O Q
MEMBRANE 
BOUND RAS
FPP
C-OMe
P F T ase
Méthylation, membrane 
translocation and 
palmitoylation
a  CAAX I
Cytosol
CAAX
Protease
T
AAX
Figure 2.2 Post-translational modification of ras
FPP=famesyl pyrophosphate, PFTase=protein famesyl transferase, C=cysteine, A=leucine, 
isoleucine or valine, X=methionine (in K-ras) or serine (in H-ras), F=famesyl group, AAX=three 
cleaved amino acids, C=carboxy-terminal cysteine, C-OMe=methylated cysteine
Following attachment of the famesyl group, proteolytic cleavage of the AAX residues 
takes place, followed by carboxymethylation (Clarke, 1992). Due to the presence o f a 
cysteine residue upstream from the CAAX moiety, some ras proteins (H-ras, N-ras and K- 
ras4A) undergo a further step in that a -SH  group on the penultimate cysteine residue is 
palmitoylated, this reaction being reversible. K-ras4B has a lysine rich sequence which
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allows it to complete its attachment to the plasma membrane (reviewed in Adjei, 2001). 
The ras protein may alternatively undergo geranylgeranylation. It is the amino acid in the 
X position which determines whether the protein undergoes famesylation or 
geranylgeranylation (Casey, e t  a l ., 1991; Yokoyama, e t  a l ., 1991). When leucine is in the 
X position the protein will undergo geranylgeranylation (reviewed in Sinensky, 2000).
2.1.5 Activation of Ras
Ras is a membrane-bound GTPase that is required for connecting growth factor signaling 
to the intracellular phosphorylation cascade. Figure 2.3 shows that the active form of ras 
has a molecule o f GTP bound in the nucleotide binding site, whereas the inactive form of 
ras contains a guanine diphosphate (GDP) molecule in that site.
Inactive
Downstream Effectors
Active
Figure 2.3 Activation of ras
Ras acts as a molecular switch, alternating between its active and inactive state as required. 
When activated, ras plays an important role in a number of pathways necessary for cell 
growth and maintenance.
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The integral GTPase activity of ras therefore converts active ras-GTP into inactive ras- 
GDP The switch is controlled by guanine nucleotide exchange factors (GEFs) and 
GTPase activating proteins (GAPs) The binding of GTP to ras is promoted by GEFs 
(Quilham, et a l, 1995), whereas, GTP hydrolysis and hence ras-GDP is promoted by 
GAPs (Bollag and McCormick, 1992) GEFs and GAPs are themselves controlled by cell 
surface receptors such as epidermal growth factor receptor (EGFR)
Ras is a membrane-bound GTPase As mentioned above the most prevalent dominant 
mutations in ras m codons 12, 13, and 61 cause a defect in the active ras-GTPase activity 
such that it is always in the active ras-GTP form This gives a false signal to activate 
growth-promoting genes and undesired cell proliferation takes place even when growth 
factors are not present
Figure 2 4 Role of adaptor proteins m ras regulation, leading to the activation of ras (taken from Cooper, 
1995) For ras to become active it must become localized at the plasma membrane Adaptor 
proteins play an important role in this process
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Growth factor receptors such as EGFR are membrane-bound tyrosine kinases which are 
upstream of ras m the signal transduction pathway For ras to be activated, EGF 
(epidermal growth factor) must bmd to EGFR (Figure 2 4) When EGF and EGFR bind, 
EGFR’s tyrosme-kmase activity is stimulated, the cytoplasmic tail of EGFR is 
autophosphorylated on tyrosine residues, the result being a SH2 (src homology 2) protein 
binding site The Sh2 domain of the adaptor protein Grb2 binds to the phosphorylated 
EGFR tail, while the two Sr3 domains of Grb2 bmd to the Sh3 binding sites on SOS (son 
of sevenless) winch is a GEF The activation of EGFR results m Grb2 bringing SOS to the 
membrane to activate ras SOS promotes the transformation of ras-GDP to ras-GTP via 
changes m the conformation of ras The result of these conformational changes is the 
dissociation of ras from the GDP molecule (reviewed in Adjei, 2001) Cells that express 
constitutive mutants of EGFR constitutively activate ras through the Grb2-SOS adaptor 
complex Once ras is bound to a GTP molecule it is m its active state, and becomes 
involved with a number of downstream effectors leading to cell growth
2 16 Downstream Effectors of Ras
Figure 2 5 presents the three most understood signal transduction pathways These 
involve mitogen activated protein kinase (MAPK), phosphatidylmositol-3-kinase (P13K), 
and RalGDS (involving Rac and Rho) The MAPK pathway leads to the transmittance of 
signals into the cell, the result being cell proliferation Active ras bmds to the Ras Binding 
Domain (RBD) of raf There are three forms of raf A-raf, B-raf, C-raf (Gunter, et a l, 
1994) with studies suggesting that C-raf-1 plays an important role in ras signalling 
(Momson, 1990, Koide, et a l, 1993) This bindmg localises raf to the membrane At this
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stage of the process ra f  s serine/threonine specific kinase activity is triggered. Raf 
phosphorylates mitogen extracellular signal regulated kinase (MEK protein kinase). MEK 
then phosphorylates cytosolic MAP kinases on threonine and tyrosine residues. Once 
activated these kinases localise to the nucleus where phosphorylation o f transcription 
factors can take place, leading to the induction of immediate-early genes e.g. Fos and Jun. 
Raf can activate other kinases that are also involved with additional transcription factors 
(reviewed in Campbell, e t  a l . , 1998).
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growth factor 
receptors
6AP/NF1
Post-translatlonai
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Cytoskeletal
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Figure 2.5 Downstream targets of ras (taken from Johnston, 2001). This diagram brings together all the 
processes involved in cellular signaling of ras, beginning with localization of ras to the 
membrane, post-translational modification of ras, and signal transduction leading to regulation 
of cell proliferation.
RalGDS also plays a part in the proliferative role o f ras (reviewed in Shields, e t  a l . , 2000). 
Rac and Rho play a key part in cytoskeletal organisation and when activated by mutated 
ras lead to the invasiveness of transformed cells (reviewed in Adjei, 2001).
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PI3K inhibits activation of Bad, Caspase 9 and Bc1-xl all of which are involved in 
inducing apoptosis of the cell Both AKT (a serme-threonme kinase and a downstream 
effector of PI3K) and PI3K can lead to the activation of NF-kB which plays an anti- 
apoptotic role therefore having implications m cell survival
2 17 Strategies to Target Cancer via the Ras Pathway
Many strategies have been devised to impair the dominant activity of ras and are reviewed 
in detail in Kloog and Cox (2000) These include dislodging ras from its membrane 
anchorage sites (Marom, et a l , 1995), restoration of ras GTPase activity (Ahmadian, et 
a l , 1999), interference with interactions between ras and its downstream effectors 
(Hermann, et a l , 1998), use of ras antisense oligonucleotides (Aoki, et a l , 1995), use of a 
reovirus (Coffey, et a l , 1998) or use of PFTase inhibitors (Gibbs, et a l , 1994, Cox and 
Der, 1997, Kohl, et a l , 1993, James, et a l, 1993) The latter have been shown not to 
interfere with normal cell proliferation and are relatively non-toxic (James, et a l, 1994) 
As discussed above famesylation of ras proteins by PFTase is an essential step for their 
binding to internal plasma membranes and for activation of events downstream of ras (i e 
activation of Raf kinase, MAPK kinase, MAP kinase and phosphorylation of fos and jun) 
leading to cell proliferation (Stacey, et a l, 1991) Non-faraesylated mutants of oncogemc 
ras that cannot appropriately localise mto the plasma membrane remain no longer 
transforming and have been shown to display a dominant inhibitory phenotype to 
antagonise the activity of membrane-bound oncogemc ras (Stacey, et a l , 1991)
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Components of dietary fat have been shown to differentially modulate oncogemc ras 
expression Several studies demonstrated that vegetable oils high m LA enhanced colon 
carcmogenesis m rats (Bull, et a l , 1981, Deschner, et a l , 1990, Reddy, et a l , 1991, 
Reddy, 1994) On the other hand, dietary fish oil supplementation reduced growth of 
colomc polyps in a phase II clinical trial (Anti, et a l , 1992) In an experimental model of 
colon carcmogenesis, ras levels were higher m rats fed a high fat diet composed of com oil 
(59% omega-6 and 1 2% omega-3 fatty acids) compared to rats fed a high fat fish oil diet 
(8% omega-6 and 31% omega-3 fatty acids) Further analysis of the occurrence of 
tumours showed that higher expression of ras correlated with increased mcidence and 
multiplicity of grossly visible colon tumours whereas, m animals fed the high fish oil diet 
lower expression of ras correlated with decreased mcidence and a lower multiplicity of 
colon tumours (Singh, et a l, 1997a) Dietary fish oil also resulted in increased 
accumulation of ras m the cytoplasm with a simultaneous decrease in levels of membrane- 
bound ras
Subsequently, Singh, et al (1998) demonstrated faraesylation of ras could be influenced 
by the type and amount of dietary fat and that this influenced the promotion and 
progression stages of colon cancer Their study demonstrated that a diet containing fish oil 
reduced PFTase activity m the azoxymethane-mduced rat colon cancer model, whereas a 
diet high in corn oil mcreased PFTase activity It was demonstrated that com oil increased 
ras expression and localization in the rat colon without affecting famesylation of ras 
(Davidson, et a l, 1999) In another study the elevated ras membrane cytosol ratio m
2 1.8 Effect of Dietary Fat on Ras
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malignant transformed young adult mouse colon (YAMC)-Ras cells, overexpressing v-H- 
Ras, supplemented with com oil was not due to mcreased famesyl protein transferase 
activity or prenylate state as nearly all detected ras was m the prenylated form This study 
demonstrated that the ras membrane cytosol ratio was reduced m docosahexaenoic acid 
(DHA) treated cells compared to LA treated cells DHA partially blocked events 
downstream of ras such as reduction of the effector MAP kinase (Collett, et a l, 2001) A 
decrease in cellular AA was also observed, a known antagomser of GAPs (Tsai, et a l , 
1991) Reduction in AA would be expected to lead to reduced antagonism of GAPs and m 
turn a reduction m GTP bound ras Inhibition of ras association with membranes could 
also be due to an interference with palmitoylation, a process necessary for localisation of 
ras at the inner leaf of the plasma membrane (Hancock, et a l, 1989, James and Olson, 
1989) Overall it is likely that dietary fat affects ras expression, membrane localization 
and/or signaling pathways known to play a role in tumour development
Hydroxymethylglutaryl CoA (HMG-CoA) reductase, the rate-limiting enzyme in 
cholesterol biosynthesis, catalyses the formation of mevalonate, a precursor to famesol 
Goldfarb and Pitot, (1971) observed that dietary fat can interfere with the activity of this 
enzyme El-Sohemy and Archer (1997) demonstrated a reduction in HMG-CoA reductase 
due to dietary fish oil which would lead to a decrease in levels of famesol available for the 
famesylation reaction These studies strongly suggest that individual components of fat, 
particularly n-3 PUFAs, may inhibit cancer development by interfering with post- 
translational modifications and membrane localisation of ras (Singh, et a l, 1997a, Singh, 
el al, 1998)
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Previously, it was found that the c9, ¿1 1 CL A isomer significantly reduced PFTase activity 
m a colon cancer cell line (SW480), a cell line m which the K-ras mutation is 
overexpressed However, the ¿10, c l2 CLA isomer enhanced PFTase activity This 
suggests that the anticarcinogemc activity of the c9, ¿1 1 CLA isomer may be due to an 
inhibition of membrane ras (O’Shea, 2000) One of the objectives of the present study was 
to determine if a CLA mixture of isomers or specific CLA isomers have an inhibitory 
effect on ras expression Of the individual CLA isomers, c9, ¿11 has been implicated as 
the most biologically active because it is the predominant isomer incorporated into the 
phospholipids of cell membranes (Ip, et a l , 1991, Hayek, et a l, 1999) However, more 
recent studies have shown the ¿10, cl2 CLA isomer to be even more potent In colon 
cancer cell lines the potent anticarcinogemc effects of CLA have been attributed either to 
mixtures of CLA isomers that contain primarily the c9, ¿11 and ¿10, cl2 forms m 
approximately equal proportions, with other CLA isomers at considerably lower levels 
(Ha, et a l , 1990, Schut, et a l, 1997, Panza and Hargraves, 1985) or to the pure c9, ¿11 
isomer or the pure ¿10, cl2 CLA isomer (Ip, et a l, 1999) A dose- and time-dependent 
growth inhibitory effect, induction of apoptosis and an induction of antioxidant enzymes 
m CLA-treated mammary and colon cancer cells as an adaptive response to induction of 
lipid peroxidation by synthetic CLA (O’Shea, et a l , 1999, Miller, 2003, Miller, et a l , 
2003) and CLA-ennched milk fat (O’Shea, 2000, Miller, 2003) has previously been 
reported
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The aim of this study was to determine if a mixture of CLA isomers shown to be 
anticarcmogemc (Hayes, et a l , 1997, O’Shea, et a l , 1999, O’Shea, et a l , 2000, 
Scheniberg and Krokan, 1995, Shultz, et a l , 1992) or if CLA in the pure form (c9, ¿11 and 
t \0, cl2 CLA), inhibited cell growth of the human colon cancer lme, SW480, via 
modulation of ras expression
2 19 Objective of Experiment
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2 2 Materials and Methods 
2 2 1 Materials
Human colon (SW480) cancer cell lines were obtained from the American Type Culture 
Collection, (Manassas, VA) Culture media and supplements were purchased from 
GIBCOBRL (Paisley, Scotland) The SW480 cells were maintained m Dulbecco's 
Minimum Essential Medium (DMEM) supplemented with 5% (v/v) fetal bovine serum, 
0 2 mM L-glutamine, 1 mM HEPES, and 1 umt/ml penicillin and streptomycin Tnton-X 
100, linoleic acid (LA) and trans-vaccemc (TVA) were purchased from Sigma-Aldrich 
Ireland L td, (Dublin) The mixture of CL A isomers were obtained from Nu Chek Prep 
Inc (Elysian, MN), and pure c9, i l l  and ¿10, cl2 CLA isomers were obtained from 
Matreya (Pleasant Gap, PA) Primary antibody, pan-ras monoclonal antibody, Ab2 and 
p21 H-ras standard were obtained from Oncogene (Oncogene Science, Manhasset, NY)
i
Secondary antibody, anti-mouse horse radish peroxidase (HRP) antibody was purchased 
from Amersham (Amersham, Little Chadford, Buckinghamshire, UK) Microcon 
centrifugal filter devices (YM-10, with molecular cut off of 10,000 kDa) were obtained 
from Milhpore (Milhpore Corporation, Bedford, MA) Hybond enhanced 
chemilummescence (ECL) membrane was purchased from Amersham, Little Chadfort, 
Buckinghamshire, UK The Trans-blot electrophoretic transfer cell was purchased from 
Bio-Rad, Hemel Hempstead, Hertfordshire, UK
2 2 2 Cell Viability
SW480 cells were seeded at 1 x 106 cells m 75cm2 flasks m DMEM (O’Shea, et a l , 1999) 
The pH of the media was maintained at 7 2-7 4 by a required flow of 95% air and 5%
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C 02 Cells were cultured for 24 h to allow the cells to attach to the substratum The 
medium was then replaced with medium alone containing ethanol to a final concentration 
of 0 1% (v/v) (control) or medium supplemented with 20 |xg/ml CLA, LA, c9, ¿1 1 and ¿10, 
cl2 CLA dissolved in ethanol Following 4 days of incubation, cells were harvested using 
trypsm-EDTA and counted using trypan blue exclusion
2 2 3 Cell Culture for Western Blot Analysis
SW480 cells were cultured and maintained as described m Section 2 2 2 SW480 cells 
were seeded at 5 x 106 cells/150cm2 flask m DMEM (O’Shea, et a l , 1999) The media 
was then replaced with media containing either (l) a CLA mixture of isomers (11) c9, ¿11- 
CLA (111) rlO, cl2-CLA and ( i v )  lmoleic acid (LA) (v) C18 1 ¿11 (vaccemc acid) (all at a 
concentration of 20 jig/ml and dissolved m ethanol) An equivalent volume of ethanol was 
added to a control flask Quercetin was used as a negative control at a concentration of 10 
pM Quercetm is a plant flavanoid which has been shown to inhibit ras expression m 
human colon cancer cell lines and the growth of human colon carcinoma cell Imes and 
primary colorectal tumours (Hosokawa, et a l , 1990, Ranelletti, et a l , 1992,2000)
2 2 4 Preparation of Cell Extracts
Cells were harvested after 24 h and 4 days mcubation using phosphate buffered saline 
(PBS) containing 0 25% (w/v) trypsin Cells were spun 1,000 x g for 5 mm The resulting 
pellets were washed twice m ice-cold PBS For total ras determination cell pellets were 
sonicated on ice for 10 min in 500 jiL lysis buffer (containing 10 mM sodium phosphate 
buffer (pH 7 2), 100 mM NaCl, 10 mM sodium deoxycholate, 1 mM PMSF, 1% Tnton-X
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100, 0 1 mM leupeptm and 0 2 jig/ml aprotinm) The lysates were concentrated using 
Microcon YM-10 filters The lysates were centrifuged at 10,000 x g at 4°C until 100 jiL 
remained in the upper chamber of the tube This chamber was then inverted and 
centrifuged at 1,000 x g for 3 mm to collect the concentrated lysate The protein content of 
the lysates was determined using the Bradford assay (Bradford, 1976) For membrane ras 
determination, cell pellets were sonicated on ice m 500 jiL PBS/PMSF buffer (containing 
10 mM sodium phosphate buffer (pH 7 2), 100 mM NaCl, 0 2 mM PMSF, 0 1 mM 
leupeptm and 0 2 ng/ml aprotmin) for 10 min fhe suspensions were centrifuged at
100,000 x g m a Beckman Ultracentrifuge for 1 h at 4°C The supernatant (cytosolic 
fraction) was removed and the pellet resuspended in lysis buffer as for total ras The 
suspension was incubated on ice for 20 mm followed by centrifugation at 15,000 x g for 
15 mm The resulting supernatant (membrane fraction) was removed, concentrated and 
analysed for protein content as for total ras
2 2 5 Gel Electrophoresis and Western Blot Analysis
Cell lysates were electrophoresed using 12% polyacrylamide gel, adding 70 ]ig of protein 
m loading buffer (16 \iL in total) to each well The loading buffer consisted of 62 5 mM 
Tris-HCl (pH 6 8), 2% w/v sodium dodecyl sulphate (SDS), 10% glycerol, 50 mM 
dithiothreitol (DTT) and 0 01% bromophenol blue The gel was run at a current 0 06 mA 
for 1 hr The separated proteins were transferred onto a Hybond ECL membrane in a 
Trans-blot electrophoretic transfer cell at 80V for 1 5 hr The membrane was then covered 
with Ponceau S stain (0 1% Ponceau S m 5% acetic acid) to ensure transfer of proteins To 
account for degradation of samples and differences m sample loadmg, the intensity of the
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stain was measured usmg densitometry (NIH Image, Version 1 61) and the value obtained 
was used to quantify ras, as described below Blocking buffer consisted of 5% non-fat 
dried milk m PBST The membrane was incubated with the pnmaiy antibody (1/5,000 - 
dilution in phosphate buffered saline containing 0 1% Tween-20 (PBST) and 0 5% non-fat 
dry milk overnight at 4°C followed by rinsing with PBST The membrane was incubated 
with the HRP-hnked secondary antibody 1/10,000 dilution in PBST containing 0 5% non­
fat dry milk followed by rinsing with PBST Presence of ras was analysed usmg ECL and 
autoradiography (Amersham Pharmacia Biotech Hyperprocesser, Model AM4) Ras was 
quantified usmg densitometry, with an accurate measurement being achieved by 
multiplying the intensity of a band by its area (Singh, et a! , 1997a, Cerda, et a l, 1999) 
This value was then multiplied by the intensity of the corresponding Ponceau S stain
2 2.6 Statistical Analysis
Three mdependent experiments were performed m triplicate The Student’s t test was used 
to determine significance between treatments
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A dose dependent growth inhibitory effect of the CLA mixture of isomers m both the 
MCF-7 and SW480 cancer cell lmes has been previously demonstrated (O’Shea, et a l ,
2000) High fat fish oil diets are known to inhibit tumour growth, inhibit ras expression 
(Smgh, et a l , 1997, Singh, et a l , 1998, Bartsch, et a l, 1999) and famesylation 
(Schonberg and Krokan, 1995) in animal models of breast and colon carcinogenesis The 
effect of various CLA isomer preparations and linoleic acid on growth and ras expression 
in the SW480 colon cancer cell lme was invest gated m this study
2 3 1 Growth of SW480 Cells
The Nu Chek Prep mixture of CLA isomers and the pure c9, ¿11 and ¿10, e ll CLA 
(Matreya) isomers significantly inhibited growth m SW480 cells following 4 days 
incubation at 20 ng/ml compared with control cells (Figure 2 6) The individual ¿10, c 12 
CLA isomer (51% growth inhibition, P<0 01) was slightly more effective at reducmg cell 
numbers than the c9, ¿11 CLA isomer (42% growth inhibition, P<0 01) and the CLA 
mixture of isomers (38% growth inhibition, P<0 01) LA (20 jig/ml) had a stimulatory 
effect on growth of SW480 cells following 4 days, increasing cell growth by almost 20% 
(P<0 05) compared with ethanol control
2 3 Results
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et CLArrnx c9 t i l  t l0 c l2  LA
Treatment 20 ¡ig/ml
Figure 2 6 Cell viability for SW480 cells incubated with fatty acids for 4 days (20 jig/ml Nu-Chek Prep 
CLA, c9, f ll  and ¿10, c 12 pure CLA isomers (Matreya) and LA * denotes values that are 
significantly different (P<0 05) compared with et (ethanol control) ** denotes values that 
are significantly different (P<0 01) compared with et (ethanol control)
2 3 2 Western Blot Analysis of Ras
Figures 2 7 and 2 8 show representative examples of Western blot analysis of total ras 
p21 expression in cells treated with CLA isomers, LA, and vaccemc acid (VA) all at a 
concentration of 20 jig/ml and 10 jjM quercetm for 24 h and 4 days respectively VA is a 
precursor to CLA in ruminal biohydrogenation A recent study earned out in the 
laboratory showed that VA (20 jig/ml) was converted to c9, t\ I CLA m SW480 cells and 
reduced (P<0 05) cell growth by approximately 30% (Miller, et a l , 2003) compared to 
ethanol
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Figure 2.7 Effect of fatty acids (20 ng/ml Nu-Chek Prep CLA, c9, /II and flO, cl 2 pure CLA isomers 
(Matreya), VA, LA) and 10 |iM quercetin on total ras after 24 h incubation
**P<0.01; *** PO.OOl significantly different compared with ethanol control
f  significantly different compared to quercetin, P<0.05
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Total ras is visible as a dense band or doublet due to the presence of both membrane and 
non-membrane bound ras, resolution of the doublet of total ras was more apparent after 4 
days incubation compared with 24 h mcubation
It is apparent from Figure 2 7 that quercetm inhibited total ras expression by 35% Of the 
fatty acids mvestigated, ¿10, cl2 CLA and LA were the most potent, inhibiting total ras 
expression by 32% and 25% respectively The c9, i l l  CLA isomer was less potent 
(inhibiting ras expression by 7%) compared with the CLA mix, which inhibited total ras 
expression by 16% Vaccemc acid did not have a significant (P<0 05) effect on total ras 
after 24 h mcubation
Extending the mcubation penod to 4 days resulted in a greater inhibition of total ras by all 
of the treatments, with the exception of LA (Figure 2 8) Quercetm was the most potent 
inhibitor, inhibiting total ras by 57% compared with the control The c9, ¿1 1 and ¿10, c\2 
CLA isomers, the CLA mixture of isomers and VA reduced total ras expression by 22%, 
47%, 35% and 45% respectively By contrast, the inhibition of total ras by LA after 4 days 
mcubation (24%) was similar to that observed after 24 h incubation The c9, ¿11 CLA 
isomer and LA were significantly (P<0 05) less potent as total ras inhibitors compared 
with the quercetm control
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1 2 0
Control CLA mix c9,tll tl0,c!2 LA VA Quercetin
Figure 2.8 Effect of fatty acids (20 ng/ml Nu-Chek Prep CLA, c9, t\ 1 and 110, cl 2 pure CLA isomers (Matreya), VA, 
LA) and 10 quercetin on total ras after 4 days incubation
* P<0.05; *** P<0.001 significantly different compared with ethanol control 
t  significantly different compared to quercetin, P<0.05
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Figures 2 9 and 2 10 represent examples of Western blot analysis of membrane ras p21 in 
cells treated with CLA isomers, LA, VA and quercetm for 24 h and 4 days respectively 
The ras protein was expressed as a duplet comprising mainly famesylated ras at 23 kDa 
and unfamesylated ras at 21 kDA Famesylated ras is membrane bound and this band was 
quantified usmg densitometry Figure 2 9 shows the reduction of membrane ras after 24 h 
treatment with the fatty acids compared to the control, which was taken as 100% The c9, 
i l l  CLA isomer and LA significantly (P<0 05) reduced membrane ras by 16% and 30% 
respectively The CLA mixture of isomers did not significantly (P<0 05) reduce 
membrane ras The rlO, cl2 CLA isomer and quercetm significantly (P<0 01) reduced 
membrane bound ras by 47%, and 22% respectively Vaccemc acid significantly 
(P<0 001) reduced membrane ras by 47%
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Figure 2.9 Effect of fatty acids (20 ng/ml Nu-Chek Prep CLA, c9, i l l  and ¿10, c l2 pure CLA isomers 
(Matreya), VA, LA) and 10 quercetin on membrane ras after 24 h incubation
* P<0.05; **P<0.01; *** P<0.001 compared with control
t  significantly different compared to quercetin, P<0.05
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120 n
Figure 2.10 Effect of fatty acids (20 ng/ml Nu-Chek Prep CLA, c9, t\ 1 and t \0, cl 2 pure CLA isomers (Matreya), 
VA, LA) and 10 |iM quercetin on membrane ras after 4 days incubation
**P<0.01; *** P<0.001 compared with control 
f  significantly different compared to quercetin, P<0.05
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Figure 2 10 presents the effect of the fatty acid treatments on membrane ras after 4 days 
incubation with SW480 cells The c9, i l l ,  ¿10, c 12 CLA isomers, LA and quercetm 
significantly (P<0 01) reduced membrane ras after 4 days incubation by 26%, 27%, 29% 
and 52% respectively Vaccemc acid did not significantly (P<0 05) reduce membrane ras 
compared with the ethanol control Quercetm was significantly (P<0 05) more potent at 
reducmg membrane ras after 4 days incubation
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Many mechanisms of action have been suggested for the anti carcinogenic effect of CL A, 
including a prooxidant effect (O’Shea, et a l, 1999, Schenberg and Krokan, 1995), 
inhibition of mutagen activation (Liew, et a l, 1995) and modulation of eicosanoid 
production (Belury, et a l , 1996, Li and Watkins, 1998) In addition, it has been proposed 
that growth regulatory genes such as c-myc and c-jun, may be influenced by bindmg of 
CLA to PPARs (Moya-Camarena, et a l, 1999b) Incubation of cancer cells with CLA has 
been shown to be associated with incorporation of CLA mto membrane phospholipids and 
neutral lipids (Miller, 2003) As a result of incorporation into membrane phospholipids 
CLA may modulate subsequent signal transduction pathways which depend on the proper 
membrane localisation of oncogene encoded proteins, for example ras It has been 
proposed that modulation of ras activation by a high fat fish oil diet containing 31% n-3 
fatty acids may partly explain why dietary fish oil protects against colon cancer 
development (Smgh, et a l , 1997a, 1998) Whether CLA and LA differentially modulate 
oncogemc ras expression has not been studied This study examined the effects of equal 
amounts (20 jig/ml) of various CLA preparations, VA and LA on total ras and membrane 
bound ras expression in the SW480 cell lme in which mutated K-ras is overexpressed
2 4 1 Effect of c9, i l l  CLA on Ras
Data from this study suggest that a reduction in membrane ras expression may underly the 
growth inhibitory effect of the c9, tl 1 CLA isomer The reduction m membrane bound ras 
by 16% and 26% after 24 h and 4 days respectively suggests that c9, t i l  CLA decreased 
ras membrane localisation This together with findings of a previous study showing that
2 4 Discussion
4 4
c9, 111 CLA inhibited PFTase activity suggests that diminished farnesylation and/or 
membrane localisation may result m ras remaining in its biologically inactive form thus 
preventing growth signals from reading proliferation genes m the nucleus This isomer 
also reduced total ras expression, this may suggest interference in ras transcription and/or 
degradation of ras transcripts A previous study (Ip, et a l , 1997) demonstrated that die 
anticancer effect of dietary CLA did not depend on the presence or absence of mutated ras 
in mammary tissue However, the data from tins study has been generated using a colon 
cancer cell line m which the K-ras mutation is overexpressed, hence different anticancer 
mechanisms can be expected in different cell lines and tissues The specificity of certain 
exchange factors such as Smg GDS which is specific for K-ras or Ras GRF which is 
specific for H-Ras activation (Orita, et a l, 1993, Jones and Jackson, 1998) may account 
for different ras responses to CLA treatment Another possibility for expected differences 
is that K-ras is localised to the plasma membrane differently to other Ras isoforms 
Membrane polar lipid head groups which form a high affinity bond with a stretch of lysine 
residues on K-ras4B are responsible for maintaining membrane localisation of this ras 
isoform All other ras isoforms are held deep in the plasma membrane by their palmitate 
group(s) (Roy, et a l, 1999, Sternberg and Schmid, 1999)
2 4 2 Effect of LA on Ras
The proliferative effect of LA observed m this study supports previous studies showing 
LA can stimulate cancer cell growth (Shultz, et a l, 1992, Cunningham, et a l, 1997) 
However, LA significantly reduced membrane and total ras in the SW480 cell Ime This 
suggests that LA interferes with the cell proliferation cascade downstream of ras (Collett,
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et a l, 2001) Therefore, despite reduced levels of ras, LA may interfere with effectors 
downstream of ras such as MAPK, leadmg to increased cellular proliferation (Brandy and 
Saker, 2001)
2 4.3 Effect of ¿10, cl2 CLA on Ras
Incubation with the ¿10, cl2 isomer showed a reduction in total and membrane bound ras 
in addition to an antiproliferative effect m the cell lme However, this isomer caused a 
66% mcrease in the activity of PFTase towards exogenous H-ras (O’Shea, 2000) This 
suggests that tins isomer inhibits SW480 cell growth by targeting ras gene expression 
rather than famesylation of ras One theory may be that although PFTase activity is 
stimulated, famesylation is reduced due to inhibition of ras gene expression A likely 
consequence of a reduction m the amount of ras protein m the cytosol that is available for 
famesylation is a reduction m membrane bound ras and in turn cell proliferation 
Therefore mcreased activity of PFTase is redundant in the absence of adequate 
concentrations of its substrate The ¿10, c 12 CLA isomer may also target events 
downstream of ras famesylation and thereby inhibit proliferation Such downstream 
effectors include NF-kB which has an anti-apoptotic function (Irani, et a l, 1997, 
Romashkova and Makarov, 1999, Ozes, et a l , 1999), or the AKT/PKB pathway which 
promotes cell survival (Khwaja, 1999)
2 4 4 Effect of Mixture of CLA Isomers on Ras
The two predominant CLA isomers inhibited both membrane and total ras after 24 h and 4 
days mcubation when present in culture media at a concentration of 20 }ig/ml in pure
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form However, the CLA mixture of isomers containing 6 ng/ml c9, ¿11 and 6 jig/ml ¿10, 
c l2 CLA did not inhibit membrane bound ras, whereas this treatment inhibited PFTase 
activity (O’Shea, 2000) and was found to have a significant effect on total ras after 24 h 
and 4 days m the SW480 cell lme This indicates a possible effect at gene level, where the 
mixture of CLA isomers may be inhibiting ras gene expression The K-ras mutation is 
overexpressed in the SW480 cell line K-ras can become membrane bound by either 
famesylation or geranylgeranylation and both processes must be inhibited in order to 
inhibit membrane localization of K-ras (Whyte, et a l , 1997) Although a previous study 
showed that the CLA mixture of isomers containing 6 pg/ml c9, ¿11 and 6jig/ml ¿10, cl2 
CLA inhibited exogenous H-ras famesylation, no studies have been conducted on the 
affect of specific CLA isomers on K-ras famesylation or on the geranylgeranylation 
process to determine which isomers, if any, might have a dominant effect and to determine 
the critical concentration at which an effect is observed
2 4 5 Effect of Vaccenic Acid on Ras
Vaccemc acid, a precursor to CLA, has been found to inhibit growth of SW480 cells after 
4 days incubation (Miller, et a! , 2003) In this study it was found that 24 h mcubation 
with VA was found to inhibit membrane ras by 47%, however, mcreasmg the mcubation 
penod to 4 days resulted m VA not effecting membrane ras Miller, et al (2003) found 
that SW480 cells are capable of converting VA to c9, ¿11 CLA -  29 4% of 20p,g/ml VA 
was converted to c9, ¿11 CLA after 4 days mcubation with SW480 cells The reduced 
inhibitory effectiveness of VA after 4 days compared to 24 h may be due to unavailability 
of VA due to its involvement m conversion to c9, ¿11 CLA It is likely that the extent of
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conversion to c9 ,¿11 CLA at a concentration of approximately 6 jig/ml was madequate to 
inhibit membrane ras Total ras was not affected by incubation of SW480 cells with VA 
for 24 h However, VA significantly reduced (P<0 001) total ras when the incubation 
period was extended to 4 days This inhibitory affect may be due to the combmed affect of 
VA and the c9, tl 1 CLA produced after 4 days incubation
2 4 6 Conclusions
Ras is involved m a number of complex signalling pathways atfecting growth 
Interference with several steps in these pathways can affect the end result This study 
suggests that CLA isomers may modulate the activity of ras by affecting production and/or 
localisation The fact that both N- and K-ras can undergo famesylation and 
geranylgeranylation further complicates the issue It is important that the effects of CLA 
on downstream targets of the ras pathway be studied It has also been shown that activated 
ras can up-regulate bcl-2, a suppressor of apoptosis (Kmoshita, et a! , 1995) Therefore, it 
may be possible that a reduction of ras due to CLA treatment may underly the down 
regulation of bcl-2 by CLA and hence induction of apoptosis, reported by Miller, et al 
(2002)
2 4 7 Summary
Ras oncoproteins have been implicated m a phosphorylation cascade which results m the 
activation of proliferation genes and, m turn, tumour development The objective of this 
study was to determine if the anticarcinogemc fatty acid CLA inhibited ras in the SW480 
cancer cell Ime A mixture of CLA isomers (c9, t il- ,  ¿10, cl2-, el l ,  ¿13- and mmor
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amounts of other isomers), c9, ¿11 CLA, ¿10, c 12 CLA (all at 20 |ig/ml) significantly 
(P<0 01) suppressed growth of SW480 cells by 38%, 42% and 51% respectively following 
4 days mcubation compared with untreated controls Incubation with LA (20 jig/ml) had a 
significant (P<0 05) stimulatory effect (-20% increase) on cell growth after 4 days Of the 
CLA isomers analysed the ¿10, cl2 isomer appeared to be the most potent ras inhibitor 
This isomer reduced total ras by 32% (P<0 01) and 47% (P<0 001) after 24 h and 4 days 
mcubation respectively, while c9, ¿11 CLA reduced total ras by 7% (P<0 01) and 22% 
(P<0 001) after 24 h and 4 days respectively The ¿10, c l2 CLA isomer reduced 
membrane ras to a similar extent as the c9, ¿11 isomer after 4 days incubation, but at 24 h, 
was more potent than c9, ¿11 CLA reducing membrane ras by 47% (P<0 01) after 24 h 
compared with 16% (P<0 05) by c9, t l 1 CLA Although LA was found to be growth 
stimulatory after 4 days mcubation, this fatty acid reduced both total and membrane ras 
after 24 h and 4 days, however this effect did not appear to be time dependant with total 
ras reduced by -25% after 24 h and 4 days, and membrane ras reduced by ~30% after 24 h 
and 4 days The CLA mixture of isomers, which contained primarily c9, ¿11 and ¿10, c l2 
CLA, reduced total ras in a time dependant manner, however only a small reduction m 
membrane ras was observed after 24 h and no significant effect after 4 days Vaccemc 
acid, a CLA precursor, only inhibited total ras after 4 days mcubation and membrane ras 
after 24 h mcubation The results suggest that measurement of ras expression alone cannot 
account for growth effects produced by these fatty acids in the SW480 cell line
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CHAPTER 3
A N T I C A R C I N O G E N I C  A C T I V I T Y  O F  
C L A  P R O D U C E D  B Y  
B I F I D O B A C T E R I A
3.1 Introduction
3.1.1 Ruminal Biohydrogenation and Microbial CLA Production
In milk, CLA is produced directly in the rumen as a by-product of microbial 
biohydrogenation of LA (Harfoot and Hazlewood, 1997) and indirectly from VA. 
Vaccenic acid is a product of further biohydrogenation of c9, t\ 1 CLA and is converted 
back to c9, t\ 1 CLA by the action of A9-desaturase enzymes in the mammary gland of the 
lactating ruminant (Griinari, et al., 2000). Consequently CLA content of milk is markedly 
different from the CLA content of the diet of ruminant animals and is strongly influenced 
by diet (Chilliard, et al., 2000; Stanton, et al., 2003).
Ci8:2cis~99 cis-\2 (linoleic acid)
Linoleate os-12, trans-11 isomerase
Butyrivibrio fibrisolvens
Ci82cis-9, trans-\ 1 conjugated octadecadienoic acid (Rumenic acid)
Ci8;i trans-\ 1 octadecamonoenoic acid (vaccenic acid)
!H
Ci8;o stearic acid
Figure 3.1 Ruminal biohydrogenation of linoleic acid
The first step in the ruminal biohydrogenation of LA involves its isomérisation to 
preferentially form the c9, /II CLA isomer (Kepler, et al., 1966) (Figure 3.1). This 
isomer has been given the name rumenic acid (Kramer, et al. 1998). The reaction is
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catalysed by LA isomerase produced by ruminal bactena such as Butyrmbno fibnsolvens 
(reviewed in Harfoot and Hazlewood, 1988) Once formed, the c9, i l l  CLA isomer may 
be absorbed or may undergo additional biohydrogenation in the rumen to form VA which 
is further biohydrogenated to produce Cl 8 0 (steanc acid) This reaction is much slower 
than the previous one and so leads to an accumulation of VA m the rumen (Keeney, 
1970) It has been suggested that biohydrogenation is a detoxification process used by 
bactena to protect against PUFAs (Dawson and Kemp, 1970), which are known to be 
highly toxic (Kepler and Tove, 1967)
3 1 2  Microbial CLA Production
Chin, et al (1994) demonstrated that microflora isolated from the intestine of rats fed a 
diet containing LA had the ability to form the c9, /II CLA isomer Some strains of dairy 
starter cultures have also been shown to possess the ability to produce CLA The c9, t\ 1 
isomer was the predominant CLA isomer found, accounting for as much as 70% of total 
CLA (Jiang, et a l, 1998) The pathway utilised by Propiombactena freudenreichu subsp 
freudenreichii and Propiombactena freudenreichu subsp shermami differed from that of 
Butyrmbno fibnsolvens m that higher concentrations of C18 1 c9 (oleic acid) were 
produced dunng LA biohydrogenation by the dairy starter cultures compared to high 
levels of VA dunng LA biohydrogenation by the ruminant bactena This study also 
demonstrated that the presence of components such as 0 1% Tween-80 and 3% milk 
protein influenced the microbial production of CLA Such components counteract the 
antimicrobial effect of fatty acids such as LA (Dubos, 1947, Ledesma, et aJ, 1977, Baker, 
et a l , 1983, Cummins and Johnson, 1986, Boyaval, et a l, 1995) It has also been
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proposed that milk proteins may act as hydrogen donors for the production of CLA in 
cheese (Gurr, 1987) Other strains such as Lactobacillus acidophilus (Lin, et a l , 1998, 
Kishrno, et a l, 2002) and Bifidobacteria strains B breve and B dentium (Nordgren, 1999, 
Coakley, et al 9 2003) have been shown to be capable of producing CLA from LA After 
selecting CLA producing strains from a range of intestinal and probiotic strains it was 
demonstrated that of the strains studied, Bifidobacterium in particular B breve and B 
dentium produced the highest concentration of CLA with B breve NCFB 2258 converting 
65% of LA to c9, t\ 1 CLA (Coakley, et a l , 2003) A pathway for the production of CLA 
by L acidophilus was suggested by Ogawa, et al (2001) It was found that incubation of 
LA with L acidophilus under microaerobic conditions resulted m the formation of 
hydroxy fatty acids and in turn c9, i l l ,  ¿9, cl 1 and t9, i l l  CLA isomers at concentrations 
as high as 5 mg/ml The concentration of substrate and incubation period are critical in 
optimising production of CLA using such cultures (Lin, et a l, 1999a)
3 13 Probiotics and Cancer
Probiotics are bacteria which impart beneficial health effects on the host when ingested 
and have been defined as viable microorganisms that (when ingested) have a beneficial 
effect in the prevention and treatment of specific pathologic conditions (Havenaar and 
Huis m’t Veld, 1992) It was Metchnikoff (1907) who suggested that these effects are due 
to the positive influence of probiotics on the intestinal microorganisms Many health 
benefits have been attributed to probiotics some of which have also been attributed to 
CLA e g stimulation of the immune system (Sekine, et a l, 1995, reviewed m Belury,
2002) and inhibition of carcinogenesis (reviewed in Hirayama and Rafter, 2000, Holzapfel
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and Schillmger, 2002, reviewed in Belury, 2002) Singh, et al (1997b) and Abdelah, et al 
(1995) both demonstrated the inhibitory effect of Bifidobacterium strains agamst colon 
cancer
In relation to carcinogenesis, a number of mechanisms have been suggested Probiotics 
may inhibit cancer development by (1) inhibiting bacteria that produce carcinogens after 
certain reactions, (2) direct inhibition of tumour formation, (3) inactivation of carcinogens 
(reviewed in Rolfe, 2000) -  these possible mechanisms are discussed below Cellular 
proliferation in colomc crypts of patients with colon adenocarcinomas was reduced due to 
treatment with L acidophilus and B bifidus (Biasco, et a l , 1991) B longum has been 
associated with inhibition of azoxymethane induced colon adenocarcinomas and aberrant 
crypt foci (ACF) in male F344 rats (Kulkami and Reddy, 1994, Singh, et al, 1997b) In 
addition, B longum inhibited 2-ammo-3-methylimidazo [4,5-f] quinoline (IQ) induced 
mammary tumours and to a greater extent colon tumours m F344 rats (Reddy and 
Rivenson, 1993) A number of studies have demonstrated that mgestion of L acidophilus 
or L casei resulted m reduced levels of enzymes which convert pre-carcinogens to 
carcinogens in faecal specimens (reviewed m Rolfe, 2000) These enzymes include 
glycosidase, P-glucuronidase, azoreductase and nitroreductase Thus inhibition of such 
enzymes can lead to the prevention or reduction of carcinogen formation Ornithine 
decarboxylase (ODC) is an enzyme which plays an important rate limiting role m the 
synthesis of polyammes -  essential for cellular proliferation and differentiation CLA has 
been shown previously to inhibit proliferation of human cancer cell lines (O’Shea, 2000) 
It has been demonstrated that B longum can lead to reduced levels of ODC m colon
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tumours m conjunction with a decrease m colonic mucosal cell proliferation (Reddy,
1999) B longum has also been associated with a reduction m the expression of total and 
mutated ras in colomc mucosa, correlating with a reduction in occurrence of colon 
tumours (Reddy, 1999) As demonstrated m Chapter 2, CLA has an inhibitory effect on 
ras expression m the SW480 human colon cancer cell lme Bifidobacterium has been 
shown to produce CLA from LA (Rosberg, 2002, Coakley, et a l , 2003) It may be 
possible that the antitumour effect of some Bifidobacterium species is partly due to an 
ability to produce CLA which in turn may act on ras expression
3 1 4  Objective of Experiment
It has been demonstrated that certain human derived Bifidobacteria can produce CLA 
from LA (Rosberg, et a l , 2002, Coakley, et a l , 2003) In particular, the strain 
Bifidobacterium (B breve NCFB 2258) could convert up to 65% LA to CLA with smaller 
amounts of ¿9, i l l  CLA also formed (Coakley, et a l , 2003) The objective of this study 
was to examine the anticarcinogemc activity of fatty acids produced by selected 
Bifidobacteria, m particular c9, i l l  and t9, i l l  CLA, against the SW480 colon cancer cell 
line The fatty acids produced in the media due to fermentation of LA enriched media by 
B breve NCFB 2258 were compared with that of another Bifidobacterium strain {B lactis 
Bbl2) strain as well as unfermented media, rich in LA
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3 2 Materials and Methods 
3 2 1 Materials
Human colon (SW480) cancer cell line was obtained from the American Type Culture 
Collection, (Manassas, VA) Culture media and supplements were purchased from 
GIBCOBRL (Paisley, Scotland) The SW480 cells were maintained in DMEM 
supplemented with 5% (v/v) fetal bovine serum, 0 2 mM L-glutamine, 1 mM HEPES, and 
1 unit/ml of penicillin and streptomycin CLA was obtained from Nu Chek Prep Inc 
(Elysian, MN, USA), this material consisted of a mixture of isomers -  21% cl 1, il 3, 29% 
¿10, cl2, 29 5% c9, ¿11, and 12 3% c8, ¿10 CLA and pure ¿9, ¿11 CLA was purchased from 
Matreya and pure c9, ¿11 was kindly donated by Natural ASA, Norway Stearic acid was 
purchased from Sigma Chemical Co St Louis, MO, USA TVam-vaccemc acid was 
purchased from Sigma-Aldrich Ireland Ltd, (Dublin) Isopropanol (99% purity) was 
obtained from Alkem Chemicals Ltd Cork, Ireland Hexane (99% purity) was obtained 
from LabScan Ltd Dublin, Ireland GC column Chrompack CP Sii 88 column was 
purchased from Chrompack, Middleburg, The Netherlands B breve NCFB 2258 and B 
lactis Bbl2 (previously obtained from the National Collection of Food Bacteria and Clir 
Hansen respectively) were used for bioconversion of LA to CLA, as previously descnbed 
(Coakley, et a l , 2003)
3 2 2 Preparation and Extraction of Fermented Oils
B breve NCFB 2258 and B lactis Bbl2 cultures were cultured m MRS broth containing 
0 05% (w/v) cysteine and 0 5 mg/ml LA The cultures were then grown for 48 h at 37°C 
prior to lipid extraction from the supernatant The unfermented oil was prepared by the
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incubation with MRS broth containing 0 05 % cysteine and 0 5 mg/inl LA without the 
addition of a bacterial strain for 48 h at 37°C followed by the extraction of the oil To 
extract the oil, 10 ml of the fermented media were centrifuged at 2197 x g for 20 mm at 
room temperature (20°C), usmg a Sanyo Mistral 2000 R centrifuge To the 4 ml of the 
supernatant was added 0 7 5 m g C  130 as an internal standard The lipid content of the 
broth was extracted by adding 2 ml isopropanol and 1 5 ml hexane to the supernatant and 
mixed by vortexing This was followed by the addition of 3 ml of hexane, mixing using a 
vortex and centrifugation at 2197 x g for 5 mm The upper layer (hexane layer containing 
fatty acids) was removed and transferred to a screw capped glass tube and flushed with N2 
gas
Extracted lipids were methylated usmg acid-catalysed methylation by resuspendmg in 12 
ml, 4% methanohc HC1 (v/v) in methanol and mixed usmg a vortex for 10 s This w^ as 
followed by incubation at 60°C for 1 h, mixing every 10 mm using a vortex After 
incubation 2 ml of water-saturated hexane and 5 ml of hexane were added and the mixture 
was allowed to stand for 30 mm The FAME containing top layer was transferred to a tube 
and 2 ml of water-saturated hexane were added and the solution was mixed for 30 s using 
a vortex and allowed to stand for 30 mm Following this, the top layer was transferred to a 
new tube and the methylation reaction terminated by addition of 0 5 g anhydrous sodium 
sulphate and mixed for 5 s usmg a vortex This was allowed to stand for 1 h, and then the 
top layer was removed and stored at -20°C prior to GC analysis
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The free fatty acids (FFAs) were analysed using a gas liquid chromatograph (GLC-Varian 
3400, Vanan, Harbor City, CA, USA) fitted with a flame ionization detector (FID) and a 
Septum Programmable Injector (SPI) Separation of fatty acids was performed on a 
Chrompack CP Sil 88 column (100 m x 0 25 mm i d , 0 20 ^un film thickness), using He 
as carrier gas at a pressure of 33 psi The injector temperature was held isothermally at 
225°C for 10 min and the detector temperature was 250°C The column oven was held at 
an initial temperature of 140°C for 8 mm, and then programmed at an mcrease of 
8 5°C/mm to a final temperature of 200°C, which was held for 41 mm Data was analyzed 
on a Mmichrom PC system (VG Data System, Manchester, UK) The c9, tl 1 CLA isomer 
was identified by retention time with reference to CLA standards, VA and steanc acid 
were identified by retention time with reference to their standard fatty acids
3 2 3 Cell Culture
Cells were grown in 6 well plates and maintained at 37°C in a humidified atmosphere 
The pH of the media was maintained at 7 2-7 4 by a required flow of 95% air and 5% 
CO2 Initially, 5 x 104 cells were seeded in wells and cultured for 24 h at 37°C allowing 
the cells to attach to the substratum prior to treatment with the fatty acids, as descnbed 
below The medium was replaced witii medium supplemented with varying concentrations 
of fatty acids extracted from media following incubation with the 2 strains of 
Bifidobacterium Each oil was dissolved in ethanol and added to the cells to yield a final 
concentration of 84 jig of oil/ml The concentration of the oils was reduced to yield a 
concentration of 20 i^g LA/ml m the unfermented oil, which equaled an oil concentration 
of 33 jig/ml Control flasks were supplemented with ethanol to a final concentration of
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0 1% (v/v) as m experimental wells Following incubation, cells were harvested by 
treatment with 500 pL of trypsin (0 25% w/v) in PBS at 37°C for 5 mm Viable cells were 
counted after 24 h, 48 h and 4 days incubation Cell viability was determined usmg the 
Trypan Blue exclusion (0 1% w/v) method Harvested cells were resuspended in 1 ml of 
fresh media followed by addition of 200 jjL of Trypan Blue Viable cells were counted 
using an inverted microscope and a haemocytometer Non-viable cells were visible as blue 
cells and were not mcluded in the final count
3 2 4 Effect of Fatty Acid Components of Fermented Oils on SW480 Cells
As the oils may also have contained components other than the fatty acids identified by 
GC analysis it was necessary to determine if the fatty acids present had similar growth 
inhibitory effects as the fermented oils In addition, it was important to identify the fatty 
acid components responsible for the growth inhibitory effect of the oils SW480 cells were 
treated by combining synthetic isomers of the primary fatty acids present in the oils, as 
determined by GC analysis These combinations were prepared to represent the fatty acid 
composition of the three oils and hence analyse the effect of the oils on SW480 cell 
growth with respect to each individual fatty acid and different combinations of these fatty 
acids It was important to determine the growth inhibitory effect of different combmations 
of fatty acids as the inhibitoiy effect of an individual fatty acid may be altered m the 
presence of others (Noble, et a l, 1974, Hudson, et a l , 1996) Standard curves of the effect 
of each of the four fatty acids, LA, oleic acid, c9, t\ 1 and t9, t\ 1 CLA on SW480 cell 
growth were also set up in the ranges 0-55, 0-40, 0-20 and 0-10 |ig/ml respectively for 
periods of 24 h, 48 h and 4 days The concentration ranges used were representative of the
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ranges present in the oils The three time points were chosen as it has previously been 
demonstrated that CLA significantly inhibits SW480 cell growth after 4 days mcubation 
whereas LA significantly mcreased cell growth after 4 days mcubation (O’Shea, 2000) 
The other two time points of 24 h and 48 h were chosen in order to determine if growth 
inhibit on mcreased with time As the effect of the fermented oils on the growth of SW480 
cells had not been previously studied it was unportant to determine the time required to 
observe a significant effect on SW480 cell growth and to determine if  such giowth effects 
were time dependant Control flasks were supplemented with ethanol to a final 
concentration of 0 1% (v/v) as in experimental wells Following mcubation for 24 h, 48 h 
and 4 days, cells were harvested and viable cells counted as in Section 3 2 3
3 2 5 Statistical Analysis
Three independent experiments were performed in triplicate The student’s t test was used 
to determine significant differences between treatments
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After GC analysis of the fermented oils it was found that the oils consisted primarily of 
LA, oleic acid, c9, ¿11 and ¿9, ¿11 CLA as presented m Table 3 1 This chapter mitially 
describes the effects of these single fatty acids on SW480 cell growth
3 3 Results
Table 3 1 Fatty acid composition (mg/g fat) of the unfermented oil, the B Iactis Bbl2 fermented oil and the
B bieve NCFB 2258 fermented oil
Unfermented oil
(mg/g fat)
B lactis Bb 12 fermented
Oil (mg/g fat)
B breve NCFB 2258 
fermented oil (mg/g fat)
Linoleic acid 610 397 251
Oleic acid 264 400 353
c9, ¿11 CLA 80 16 239
¿9, ¿11 CLA 49 11 19
The effects of an unfermented oil extract and two microbially fermented oil extracts on 
SW480 cell growth were then analysed using the oils at a concentration of 84 \ig oil /ml 
and 33 jig oil/ml as presented m Tables 3 2 and 3 3 respectively
Table 3 2 Fatty acid composition of bactenally fermented oil treatments when at a concentration of 84 fig
oil/ml in ethanol
Fatty Acid Unfermented Oil 
jig/ml
B lactis Bbl2 Oil 
jig/ml
B breve NCFB 
2258 Oil Mg/ml
Linoleic acid 51 2 33 3 21 1
Oleic acid 22 2 33 6 29 6
c9, ¿11 CLA 07 1 4 20
¿9, ¿11 CLA 04 09 1 6
Table 33  Fatty acid composition of bactenally fermented oil treatments when at a 
oil/ml m ethanol
concentration of 33 jig
Fatty Acid Unfermented Oil 
M.g/ml
B lactis Bbl2 Oil 
___ fxg/ml
B breve NCFB 
2258 Oil ug/ml
Linoleic acid 20 13 82
Oleic acid 87 13 1 11 6
c9, ¿11 CLA 03 05 78
¿9, ¿11 CLA 02 04 06
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Finally, the effects of various combinations of the four fatty acid constituents of the oils 
(LA, oleic acid, c9, t\ 1 CLA and t9, t l 1 CLA) were examined
3 3 1 Effect of C18 Fatty Acids on SW480 Cell Growth
Figure 3 2 represents % cell viability of SW480 cells following incubation with either LA 
(0-55 fig/ml), oleic acid (0-40 fig/ml), c9, i l l  CLA (0-20 ng/ml) and t9, t i l  CLA (0-10 
jig/ml) relative to control cells (100% viability) treated only with 0 1% (v/v) ethanol 
Incubation of SW480 cells with LA (25 |ig/ml) had negligible effects after 24 h but 
increased viable cell numbers by 10% and 27% (P<0 05) after 48 h and 4 days 
respectively (Figure 3 2A) However, at higher concentrations, LA (40 and 55 fig/ml) 
significantly reduced (P<0 001) cell growth by 61% and 95% respectively after 24 h 
incubation, 82% and 92% respectively after 48 h incubation and 89% and 99% 
respectively after 4 days mcubation
Incubation with oleic acid at concentrations of 30 and 40 fig/ml significantly (P<0 01) 
reduced SW480 cell growth by 30% and 32% respectively after 24 h and by 57% and 67% 
after 48 h (P<0 001) In addition, oleic acid at a concentration of 20 fig/ml significantly 
(P<0 05) reduced SW480 cell growth by 25% after 48 h mcubation (Figure 3 2B) 
Decreased potency of oleic acid was observed after 4 days, with cell growth bemg reduced
by 32% (PO  05) and 41% (P<0 01) following incubation with 30 and 40 fxg/ml
respectively These data suggest that there is an optimum concentration (40 fig/ml) and 
mcubation period (48 h) for observing inhibition of cell growth by oleic acid
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Figure 3 2 %  viability of SW480 cells following incubation with (A) linoleic acid, (B) oleic acid, (C) c9, tl 1 CLA, 
(D) t9, i l l  CLA for 24 h (♦), 48 h (□ ), and 4 days ( • )  compared with ethanol control Analysis was 
earned out three times m triplicate, data represent the mean of the three individual experiments 
* denotes values that are significantly different compared with ethanol control after 24 h incubation  ^
denotes values that are significantly different compared with ethanol control after 48 h incubation * 
denotes values that are significantly different compared with ethanol control after 4 days incubation For 
clarity, P values are inserted in text
SW480 cell growth was not significantly affected by c9, t\ 1 CLA (5-20 ¡ug/ml) after 24 h 
incubation compared with ethanol control However, after 48 h c9, tl 1 CLA (20 fig/ml) 
significantly (P<0 05) reduced cell growth by 35% while after 4 days c9, t l 1 CLA at 10, 
15 and 20 fig/ml all reduced growth (P<0 001) by 32%, 55% and 65% respectively 
(Figure 3 2C) These data indicate the mcrease m potency of this CLA isomer with time
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The t9, t i l  CLA isomer (1-10 }ig/ml) did not significantly influence SW480 cell growth 
after 24 h incubation However, this CLA isomer at a concentration of 10 jig/ml 
significantly reduced growth by 26% (P<0 001) after 48 h incubation and by 43% 
(P<0 001) after 4 days incubation In addition 1, 2 and 5 jig/ml of t9, t i l  CLA reduced 
SW480 cell growth by 14% (P<0 05), 21% (P<0 05) and 33% (P<0 001) respectively after 
4 days (Figure 3 2D) As observed with the c9, t l 1 CLA isomer, the potency of the t9, t l 1 
CLA isomer was much greater after 4 days incubation compared with 24 h and 48 h
3 3 2 Effect of Oils on SW480 Cell Growth
SW480 cells were incubated with the unfermented oil, the B lactis Bbl2 fermented oil 
and the B breve NCFB 2258 fermented oil all at a concentration of 84 jig/ml for periods 
of 24 h, 48 h and 4 days This concentration was chosen as at this concentration the B 
lactis NCFB 2258 fermented oil contained 20 ng/ml of the c9, t i l  CLA isomer, a 
concentration winch has been shown previously to inhibit SW480 cell growth (O’Shea, 
2000) Following incubation viability of the cells was determined by Trypan Blue 
exclusion The composition of each oil at this concentration is presented m Table 3 2 As 
with the individual fatty acids (Section 3 3 1) all treatment of SW480 cells was compared 
to control cells treated with 0 1% (v/v) ethanol, the viability of which was taken as 100%
All three oils significantly (P<0 05) reduced SW480 cell growth relative to the ethanol 
control m a time dependant manner after 24 h, 48 h and 4 days (Figure 3 3) The 
unfermented oil reduced growth by 47% after 24 h (P<0 01), 83% after 48 h (P<0 001) 
and 98% after 4 days (P<0 001) Both the B lactis Bbl2 and B breve NCFB 2258
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fermented oils were significantly (P<0.05) more potent than the unfermented oil after 24 h 
(F igure 3.3) reducing growth by 62% and 57% respectively after 24 h. No significant 
difference in growth inhibition was observed between the oils after 48 h and 4 days 
incubation.
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Figure 3.3 Effect of B. lactis Bbl2 and B. breve NCFB 2258 fermented oils on SW480 cell growth 
compared with unfermented oil at a concentration of 84 jig/ml after 24 h, 48 h, and 4 days 
incubation. * denotes values that are significantly different (P<0.05) compared with 
unfermented oil.  ^ denotes values that are significantly different (P<0.05) compared with 
ethanol control (0% inhibition).
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There was no significant difference between the growth inhibitory effect of the B lactis 
Bbl2 fermented oil and that of the B breve NCFB 2258 fermented oil at each of the three 
time points
3 3 3 Effect of Fermented Oils on SW480 Cell Growth at 40% Reduced 
Concentration
At a concentration of 84 i^g/ml oil, the B breve NCFB 2258 fermented oil contained 20 
jxg/'ml of the c9, /II CLA isomer -  a concentration which has previously been 
demonstrated to be cytotoxic to the SW480 cell line (O’Shea, 2000) However at this 
concentration the unfermented oil contained a very cytotoxic concentration of LA (51 
fig/ml) as seen m Figure 3 2A LA has been shown to stimulate SW480 cell growth at a 
concentration of 20 fig/ml (O’Shea, 2000) To exclude the inhibitory effect of LA when 
the oils are present at 84 (xg/ml, the concentration of each oil was reduced to 33 i^g/ml 
before incubation with SW480 cells for 24 h, 48 h and 4 days Table 3 3 presents the fatty 
acid composition of the three oils when at a concentration of 33 |xg/ml At a concentration 
of 84 fig/ml the B breve NCFB 2258 fennented oil contained 20 jig/ml c9, t i l  CLA, 
whereas 33 jxg/ml of the unfermented oil contained 20 jig/ml LA
All three oils were significantly cytotoxic to cell growth when presented to cells at 33 
jxg/'ml after 24 h, 48 h and 4 days (Figure 3 4) The unfermented oil reduced growth by 
23% after 24 h, 62% after 48 h and 96% after 4 days The B lactis Bbl2 fermented oil 
was more potent (P<0 05) than die unfermented oil after 24 h, reducing growth by 62% 
However after 48 h and 4 days, no significant difference was observed between the 
unfermented oil and either of the two fermented oils
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Figure 3.4 Effect of B. lactis Bbl2 and B. breve NCFB 2258 fermented oils on SW480 cell growth 
compared with unfermented oil at a concentration of 33 fig/ml after 24 h, 48 h, and 4 days 
incubation. * denotes values that are significantly different (P<0.05) compared with 
unfermented oil.  ^ denotes values that are significantly different (P<0.05) compared with 
ethanol control (0% inhibition).
Figure 3.5 compares the growth inhibitory effects of the three oils at concentrations o f 84 
jig/m 1 oil and 33 jxg/ml at the various time points. It is apparent that reducing the 
concentration of the oils by 40% did not significantly reduce the inhibitory effect of the 
unfermented oil at any time point.
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Figure 3 5 Comparison between the growth inhibitory effect of 84 ng/ml (□ ) and 33 jig/ml (■ ) of 
each of the three oils after (A) 24 h, (B) 48 h and (C) 4 days incubation All data values 
are relative to ethanol control (0% growth inhibition) ** denotes values which 
significantly different (P<0 01) compared with 33 jig/ml of oil
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Only incubation of cells with B breve NCFB 2258 (33 fig/ml) for 24 h was significantly 
(P<0 01) less inhibitory than the corresponding treatment at 84 ng/ml
3 3 4 Elucidation of Inhibitory Fatty Acids m Unfermented Oil
The unfermented oil was prepared by the addition of LA to media without fermentation, 
incubated under the same conditions as the fermented oils and extracted as described in 
Section 3 2 The extracted oil was diluted m ethanol When added to SW480 cells at a 
concentration of 84 jig/inl the unfermented oil treatment consisted of 51 [ig/ml LA, 22 
jig/m 1 oleic acid, 0 7 |ig/ml c9, t\ 1 CLA and 0 4 jxg/ml t9, t l 1 CLA in ethanol
As was seen in Figure 3 3, incubation with the unfermented oil significantly (P<0 05) 
reduced cell numbers after 24 h5 48 h and 4 days incubation, with growth inhibition 
increasing with time
To obtain a clearer picture of the effect of the individual fatty acids present m the oils on 
SW480 cell growth, synthetic isomers of these fatty acids were analysed individually at 
concentrations representative of those present m each of the three oils analysed In 
addition, to account for any interactions between these fatty acids in the oils, a number of 
combmations of the fatty acids were prepared and mcubated with SW480 cells These 
preparations were called synthetic representations as they consisted of synthetically 
produced isomers of the fatty acids The LA synthetic representation of the unfermented 
oil consisted of 51 jig/ml of pure LA dissolved m ethanol
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Figure 3 6 Effect of 84 |ig/ml Unfermented Oil and the individual fatty acids present in the oil on growth 
after (A) 24 h, (B) 48 h and (C) 4 days expressed as % growth inhibition The composition of 
the Unfermented Oil and hence the Synthetic Representation (Syn Rep) was LA (51 jig/ml), 
oleic acid (OA) (22 fig/ml), c9, t\ 1 CLA (0 7 ng/ml) and t9, ¿1 1 CLA (0 4 |xg/ml) * denotes 
values that are significantly different (P<0 05) compared with ethanol control (0% inhibition), 
** denotes values that are significantly different (P<0 01) compared with ethanol control, *** 
denotes values that are significantly different (P<0 001) compared with ethanol control
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After 24 h incubation, the LA synthetic representation reduced SW480 cell numbers by 
80% (P<0 001) compared with the ethanol control (Figure 3 6A) Pure oleic acid alone at 
a concentration of 22 |ig/ml significantly reduced (P<0 05) SW480 cell growth by 15% 
after 24 h
Combimng LA and oleic acid at a concentration of 51 p.g/ml and 22 jig/ml respectively 
and incubating with SW480 cells for 24 h significantly (P<0 05) reduced growth by 48% 
compared with the ethanol control suggesting the possibility of a protective effect of oleic 
acid against the growth inhibitory effect of linoleic acid (Figure 3.6A)
A combination of LA, oleic acid and c9, ¿11 CLA at the concentrations present m the 
unfermented oil treatment also significantly reduced (P<0 05) cell growth compared with 
the ethanol control, as did a combination of all four fatty acids -  LA, oleic acid, c 9 ,111 
CLA and t9, /II  CLA (a complete representation of the unfermented oil) However, 
neither of these two combinations produced effects that were different to the combination 
of LA and oleic acid It is apparent that the inhibition (45%) caused by the complete 
synthetic representation of the unfermented oil was similar to that produced by the 
unfermented oil (47%)
Of the combinations of synthetic fatty acids used to represent the fatty acid composition of 
the unfermented oils, LA alone at a concentration of 51 jag/ml had the most significant 
inhibitory effect on SW480 cell growth after incubation for 24 h
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After 48 h LA (51 fig/ml) further reduced cell growth by 86% (P<0 001) compared with 
control cells (Figure 3 6B) Oleic acid alone (22 jig/ml) significantly reduced (P<0 01) 
cell growth by 22% after 48 h Incubation of SW480 cells with a combination of LA (51 
Hg/ml) and oleic acid (22 fig/ml) for 48 h significantly reduced (P<0 001) cell growth by 
92% A combination of LA, oleic acid and c9, t i l  CLA (0 7 |ig/ml) also reduced growth 
(84%) but was not significantly different to the effect produced by the combination of LA 
and oleic acid
The synthetic representation of the unfermented oil containing the four fatty acids 
significantly reduced (P<0 01) cell growth after 48 h by (86%) but was not significantly 
different to the effect produced by the combination of LA, oleic acid and c9, t\ 1 CLA As 
observed after 24 h incubation, it was apparent that the inhibition caused by the complete 
synthetic representation of the unfennented oil was similar to the produced by the 
unfermented oil (83%)
After 4 days incubation with SW480 cells the treatment consisting of 51 jig/m 1 of 
synthetic LA significantly reduced (P<0 001) cell growth by 98% (Figure 3 6C) Oleic 
acid alone at a concentration of 22 jig/ml significantly reduced (P<0 01) cell growth by 
24% The combination of LA and oleic acid significantly reduced (P<0 001) cell growth 
by 97% while the combination of LA, oleic acid and c9, t i l  CLA significantly reduced 
(P<0 001) SW480 growth by 98% The synthetic mixture of all four fatty acids 
representative of the unfermented oil significantly reduced (P<0 001) cell growth by 96% 
and was snnilar to the effect produced by the unfermented oil (96% inhibition) Together
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these data suggest that it was the fatty acids present in the unfennented oil, in particular 
the high content of LA, which led to the growth inhibitory effect of 84 jig/ml of the 
unfermented oil
When comparing the inhibitory effect of the treatments presented m Figure 3 6, it was 
found that the inhibitory effect of LA (51 jig/ml) significantly increased (P<0 05) with 
time (from 80-98%) Though the inhibitory effect of oleic acid (22 jig/ml) changed only 
slightly with time (from 15-24%) the effect of the combination of LA and oleic acid 
changed from 48-97% over the 4 days Similar time dependant effects were observed for 
the combination of LA, oleic acid and c9s i l l  CLA (43-98%), the combination of LA, 
oleic acid, c9, ¿11 CLA and ¿9, i l l  CLA (45-96%) as well as the unfennented oil (47- 
96%) Thus, an incubation penod of 4 days yielded optimal inhibition of SW480 cell 
growth It has previously been demonstrated that 4 days incubation with CLA are required 
to observe substantial growth inhibition of SW480 cells (O’Shea, et a l, 2000)
When added to SW480 cells at a concentration of 33 jxg/ml, the unfermented oil consisted 
of 20 ¿ig/ml LA, 8 7 (ig/ml oleic acid, 0 3 fig/ml c9, t\ 1 CLA and 0 2 ng/ml ¿9, t\ 1 CLA 
As was seen in Figure 3 4, maximum inhibition was obtained following incubation with 
the unfermented oil for 4 days Figure 3 7 presents the effects of vanous combinations of 
these four fatty acids over 24 h, 48 h and 4 days incubation periods
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Figure 3 7 Effect of 33 jig/'ml Unfermented Oil and the individual fatty acids present in the oil on growth 
after (A) 24 h, (B) 48 h and (C) 4 days expressed as % growth inhibition The composition of 
the Unfeimented Oil and hence the Synthetic Representation (Syn Rep) was LA (20 jig/ml), 
oleic acid (0 A) (8 7 ng/ml), c9, t\ 1 CLA (0 3 jig/ml) and t9, t\ 1 CLA (0 2 fig/ml) * denotes 
values that are significantly different (P<0 05) compared with ethanol control (0% inhibition), 
** denotes values that are significantly different (P<0 01) compared with ethanol control, *** 
denotes values that are significantly different (P<0 001) compared with ethanol control
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It is apparent that neither LA alone, oleic acid alone nor the combination of LA and oleic 
acid had any effect on cell growth after 24 h The combination of LA, oleic acid and c9, 
¿11 CLA had a negligible effect after 24 h but the combination of all four fatty acids -  LA, 
oleic acid, c9, t l 1 CLA and /9, t\ 1 CLA did decrease growth by approximately 18% after 
this incubation penod, similar to that produced by the unfennented oil (23%) (Figure 
3 7A)
After 48 h incubation LA alone significantly (P<0 05) increased cell growth by 5%, while 
the combination of synthetic isomers of LA and oleic acid, the combination of LA, oleic 
acid and c9, 111 CLA and the combination of synthetic isomers of all four fatty acids 
present in the unfermented oil all significantly reduced cell growth by 66% (P<0 05), 79% 
(P<0 001) and 72% (P<0 05) respectively (Figure 3 7B) As demonstrated m Figure 3 4 
the unfennented oil reduced cell growth by 62%
Following 4 days mcubation of fatty acids with SW480 cells, only the synthetic 
combinations containing c9, i l l  CLA and ¿9, i l l  CLA were inhibitory by 61-62% LA 
alone (20 fig/ml) significantly increased (P<0 05) cell growth by 10% (Figure 3 7C) In 
Figure 3 2A it was demonstrated that 25 fig/ml LA stimulated SW480 cell growth after 4 
days mcubation The unfermented oil significantly reduced (P<0 001) cell growth by 98% 
It is clear that LA did not influence the inhibitory effect of the oil at this concentration as 
the concentration of LA present in 33 fig/ml of the unfermented oil had a stimulatory 
effect on SW480 cells after 4 days mcubation Interestingly, the unfermented oil was 
significantly more potent (P<0 01) at inhibiting SW480 cell growth compared with the
synthetic mixture of all four fatty acids of the oil (61% growth inhibition) or the mixture 
of LA, oleic acid and c9, t i l  CLA (62% growth inhibition) Tins suggests that another 
inhibitory factor, more potent than c9, t i l  CLA or t9, t i l  CLA, may be present m the 
unfermented oil at the concentration tested Although the potency of the synthetic mixture 
of all four fatty acids and the combination of LA, oleic acid and c9,111 CLA seemed to 
decrease between 48 h and 4 days the potency of the unfermented oil mcreased over this 
time period These data further suggest the presence of another inhibitory factor in the oil 
which is responsible for the growth inhibitory effect of the oil at a concentration of 33 
jig/ml The diminished inhibitory effect of the synthetic fatty acids is upheld by Figure 
3 2 in which such concentrations of LA enhanced cell growth, whereas such 
concentrations of oleic acid, c9, t i l  CLA and t9, t i l  CLA had negligible effects on cell 
growth A difference m how fatty acids are presented to cells (e g bound or ‘free’) may 
also account for the difference m potency observed between the oil and the synthetic 
combination
3 3 5 Elucidation of Inhibitory Fatty Acids in B lactis Bbl2 Fermented Oil
B lactis Bbl2 was incubated m the presence of LA (0 5 mg/ml) for 48 h and the fatty acid 
composition of the spent media was analysed The fatty acids were extracted and 
dissolved m ethanol pnor to anticancer activity analysis At a concentration of 84 jag/ml 
the B lactis Bbl2 fermented oil consisted of LA (33 fig/ml) m addition to the other three 
fatty acids After 24 h incubation LA (33 ^g/ml) significantly reduced (P<0 05) cell 
growth by 30% (Figure 3 8A) Similarly, oleic acid (34 fig/ml), the concentration of oleic 
acid present m the B lactis Bbl2 fermented oil, reduced cell growth by 27% (P<0 05)
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Figure 3 8 Effect of 84 jig/ml B lactis Bbl 2 fermented oil and the individual fatty acids present in 84 jig/ml 
of the oil on growth after (A) 24 h, (B) 48 h and (C) 4 days expressed as % growth inhibition 
compared with ethanol control (0% inhibition) The composition of the B lactis Bbl 2 fermented 
oil and hence the Synthetic Representation (Syn Rep) was LA (33 |ig/ml), oleic acid (OA) (33 
fig/ml), c9, i l l  CLA (14 |ig/ml) and t9, /II CLA (0 9 fig/ml) * denotes values that are 
significantly different (P<0 05) compared with ethanol control (0% inhibition), ** denotes 
values that are significantly different (P<0 01) compared with ethanol control, *** denotes 
values that are significantly different (P<0 001) compared with ethanol control
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Both of these observations are consistent with the data shown in Figure 3 2 showing 
inhibitory effects of LA at concentrations >25 (xg/ml and of oleic acid at concentrations 
>30 fig/ml Combining LA and oleic acid at the concentrations present m the B lactis 
Bbl2 fermented oil led to greater reductions m growth (60% growth inhibition) compared 
to these fatty acids used separately
A combination of LA (33 ¿ig/ml), oleic acid (34 fig/ml) and c*9, ¿11 CLA (1 4 fig/ml) also 
reduced cell growth by 41% (P<0 05) while the mixture of synthetic isomers of the four 
fatty acids present in the B lactis Bbl2 fermented oil reduced SW480 cell growth by 54% 
(P<0 05) The B lactis Bbl2 fermented oil significantly (P<0 01) reduced cell growth by 
62% after 24 h mcubation with SW480 cells Tins inhibitory effect was not significantly 
different compared to that of the synthetic fatty acid representation of the B lactis Bbl2 
fermented oil after 24 h mcubation
After 48 h mcubation, both LA and oleic acid significantly reduced growth by 40% 
(P<0 01) (Figure 3 8B) Combining these two fatty acids in the concentrations present in 
the B lactis Bbl2 fermented oil significantly reduced growth (P<0 001) by 90% and 
therefore represented a much greater inhibition than either fatty acid alone Similar 
reductions m cell growth (92%, P<0 001) were observed following incubation with a 
combination of LA, oleic and c9, t i l  CLA and with the mixture of synthetic isomers of 
the four fatty acids (92%, P<0 001) It is apparent that the inhibition (92%) caused by the 
complete synthetic representation of the B lactis Bbl2 fermented oil was similar to that 
produced by the fermented oil itself (87%)
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After 4 days incubation all synthetic combinations containing LA reduced growth by 86- 
98% and were not significantly different The B lactis Bbl2 fermented oil significantly 
reduced (P<0 001) SW480 cell growth by 97% compared with the ethanol control (Figure 
3 8C) There was no significant difference between the growth inhibitory effect of the B 
lactis Bbl2 fermented oil and the synthetic representation of this oil which reduced cell 
growth by 95% (P<0 001) Oleic acid alone was less potent than when present m 
combination with LA, reducing growth by 42% relative to ethanol control The data 
suggest that cytotoxic concentrations of fatty acids such as LA and oleic acid are 
contributory factors to growth inhibition caused by the B lactis Bbl2 fermented oil
When added to SW480 cells at a concentration of 33 fig/ml the B lactis Bbl2 fermented 
oil consisted of 13 )ig/ml LA, 13 ¿ig/ml oleic acid, 0 5 fig/ml c9, t\ 1 CLA and 0 4 fig/ml 
(9, i l l  CLA As was seen m Figure 3 4, incubation with the fermented oil significantly 
(P<0 05) reduced cell numbers after 24 h (62%), 48 h (88%) and 4 days (99%) incubation, 
with growth inhibition increasing with time Figure 3 9 presents the effects of the various 
combinations of these fatty acids on cell growth after 24 h, 48 h and 4 days incubation
As expected neither LA nor oleic acid influenced cell growth after 24 h, 48 h or 4 days 
incubation Interestingly the combmation of LA and oleic acid did inhibit (P<0 05) growth 
by 15%, 38% and 16% after 24 h, 48 h and 4 days respectively
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Figure 3 9 Effect of 33 jig/ml of the B lactis Bbl2 fermented oil and the individual fatty acids present in 
the oil on growth after (A) 24 h, (B) 48 h and (C) 4 days expressed as % growth inhibition 
The composition of the Unfermented Oil and hence the Synthetic Representation (Syn Rep) 
was LA (13 fig/ml), oleic acid (OA) (13 ng/ml), c9, i l l  CLA (0 5 fig/ml) and t9, i l l  CLA 
(0 4 fig/ml) * denotes values that are significantly different (P<0 05) compared with ethanol 
control (0% inhibition), ** denotes values that are significantly different (P<0 01) compared 
with ethanol control *** denotes values that are significantly different (P<0 001) compared 
with ethanol control
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The synthetic combination containing LA, oleic acid and c9, ¿11 CLA had a negligible 
effect after 24 h, but decreased growth by 48% (P<0 01) and 32% (P<0 001) after 48 h 
and 4 days respectively
Interestingly, the synthetic combination of all four fatty acids significantly inhibited 
growth by 20% after only 24 h, with growth being reduced further following 48 h (25%) 
and 4 days (38%) However, this synthetic combination was less potent than the B lactis 
Bbl2 fermented oil after 48 h and 4 days suggesting that other inhibitory components may 
be present in the oil
3 3 6 Elucidation of Inhibitory Fatty Acids in B breve NFCB 2258 Fermented Oil
B breve NFCB 2258 was incubated m the presence of LA (0 5 mg/ml) for 48 h and the 
fatty acid composition of the spent media was analysed (Table 3 1) The fatty acids were 
extracted and dissolved m ethanol At a concentration of 84 jug/ml of the B breve NCFB 
2258 fermented oil consisted of 21 jig/ml LA, 30 jig/ml oleic acid, 20 pg/ml c9, ¿11 CLA 
and 1 6 |ig/ml ¿9, ¿11 CLA
After 24 h incubation, LA alone had a negligible effect but was stimulatory towards cell 
growth after 48 h and 4 days mcubation Oleic acid alone reduced cell growth (P<0 05) by 
27-37% over 4 days The combination of LA and oleic acid was inhibitory, reducing 
growth by 33-75% over the same period
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Figure 3 lOEffect 84 jig/ml of the B breve NCFB 2258 fermented oil and the individual fatty acids 
present in the oil on growth after (A) 24 h, (B) 48 h and (C) 4 days expressed as % growth 
inhibition compared with ethanol control (0% inhibition) The composition of the B breve 
NCFB 2258 fermented oil and hence the Synthetic Representation (Syn Rep) was LA (21 
|ig/ml), oleic acid (OA) (30 fig/ml), c9, i l l  CLA (20 fig/ml) and ¿9, / l l  CLA (1 6 |ig/ml) * 
denotes values that are significantly different (P<0 05) compared with ethanol control, ** 
denotes values that are significantly different (P<0 01) compared with ethanol control *** 
denotes values that are significantly different (P<0 001) compared with ethanol control
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The synthetic combinations containing c9, t\ 1 CLA and/or t9, f 1 1 CLA further reduced 
growth with the greatest inhibition (95%) observed after 4days incubation of SW480 cells 
in the presence of the combination of LA, oleic acid and c9, t\ 1 CLA At each tune point, 
the synthetic representation of the B breve NCFB 2258 fermented oil produced an effect 
similar to the fermented oil itself suggesting that the specific combination and 
concentration of oleic acid and CLA isomers present in the fermented oil account for the 
inhibition observed
The standard curve for LA (Figure 3 2A) demonstrated that 25 |ig/ml LA did not 
significantly increase SW480 cell growth after 24 h incubation, but sigmficandy increased 
cell growth after 48 h and 4 days The standard curve also demonstrated that as the 
concentration of LA is mcreased it becomes a growth inhibitor It is demonstrated m 
Figure 3 10 that 21 jig/ml LA significantly (P<0 05) increased cell growth after 48 h and 
4 days incubation Therefore it appears as though there is an optimum concentration at 
which LA stimulates SW480 cell growth Combining the data from Figure 3 2A, Figure 
3 7 and Figure 3 10 suggests that this optimum concentration is in the range of 20-25 
jig/ml LA
After 4 days incubation the growth inhibitory effect of the combination of LA, oleic acid 
and c9, t\ 1 CLA (95% growth inhibition) was significantly (P<0 05) greater than that of 
the combination of LA and oleic acid (75% growth inhibition) This suggests that the c9, 
t\ 1 CLA isomer had a significant influence on the growth inhibitory effect of the B breve 
NCFB 2258 fermented oil
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Figure 3 11 Effect of 33jig/ml of the B breve NCFB 2258 fermented oil and the individual fatty 
acids present m the oil on growth after (A) 24 h, (B) 48 h and (C) 4 days expressed as % 
growth inhibition compared with ethanol control (0% inhibition) The composition of 
the B breve NCFB 2258 fermented oil and hence the Synthetic Representation (Syn 
Rep) was LA (8 2 jig/ml), oleic acid (OA) (12 fig/ml), c9, t\ 1 CLA (7 8 ng/ml) and t9, 
f 11 CLA (0 6 fig/ml) * denotes values that are significantly different (P<0 05) 
compared with ethanol control, ** denotes values that are significantly different 
(P<0 01) compared with ethanol control *** denotes values that are significantly 
different (P<0 001) compared with ethanol control
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When added to cells at a concentration of 33 jig/ml of oil, the 5  breve NCFB 2258 
fermented oil consisted of 8 2 |ig/ml LA, 12 jig/ml oleic acid, 7 8 fig/ml c9, i l l  CLA and 
0 6 Lig/'ml ¿9, ¿1 1 CLA As was seen m Figure 3 4, incubation with the fermented oil 
significantly (P<0 05) reduced cell numbers after 24 h, 48 h and 4 days incubation, with 
growth inhibition increasing with time Figure 3 11 presents the effects of various 
combinations of these four fatty acids on cell growth Neither LA nor oleic acid alone 
influenced cell growth The combination of LA and oleic acid was negligible after 24 h 
and 4 days, though this treatment reduced growth by approximately 25% (P<0 05) after 48 
h
The combinations containing c9, ¿11 CLA and ¿9, ¿11 CLA reduced growth by 
approximately 20-40% Though the synthetic combination of the B breve NCFB 2258 
fermented oil wras as potent as the oil up to 48 h, the oil was more potent than the synthetic 
representation of the oil after 4 days suggestmg that other inhibitory components m the oil 
may have become active dunng the longer incubation penod
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Many beneficial health effects have been associated with ingestion of probiotic bactena 
(reviewed in Zubillaga. et a1, 2001), including anticancer activity, although mechanisms 
of action have not been clearly established Some microbial strains used in food 
fermentations have been shown to have an ability to produce CLA, including 
propiombacteria (Jiang, et a l, 1998) and Bifidobacteria (Coakley, et a l, 2003) The aim 
of this study was to investigate whether the fatty acids produced from LA by two probiotic 
strains of Bifidobacterium, B breve 2258 and B lactis B b li, were inhibitory towards the 
human colon cancer cell line, SW480
Each of the three oils -  an unfermented oil, and two oils produced by the fermentation of 
lmoleic acid by B lactis Bbl2 and B breve NCFB 2258 -  was used to treat SW480 
human colon cancer cells at two concentrations of oil (84 and 33 jig/ml) These two 
concentrations were chosen m order to observe the antiproliferative activity of the fatty 
acid components present in the oils at different concentrations A synthetic representation 
of the four major fatty acids present m the oils were also used to treat the cells at 
concentrations representative of the concentrations present m the bactenally transformed 
fatty acids The four primary fatty acids present were LA, oleic acid, c9, t\ 1 CLA and ¿9, 
111 CLA The effects of these fatty acids formed microbially were investigated 
individually In addition, various combinations of fatty acids were used to determine 
effects of combining the fatty acids on SW480 cell growth Combining the four fatty acids 
present m the corresponding concentrations, formed models of the oils consisting of 
synthetically produced fatty acids
3.4 Discussion
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The unfermented oil was not exposed to any bactena and was extracted from media 
enriched m LA Linoleic acid was present at a very high concentration m the unfermented 
oil due to the fact that it was used as the substrate for production of CLA However, small 
quantities of other fatty acids were also found to be present after incubation m the absence 
of any microbial fermentation The reason for this is not known but may relate to some 
non-enzymatic hydrogenation of LA occurring under incubation conditions At a 
concentration of 84 }ig/ml the unfermented oil and the mixture of synthetic isomers of the 
four fatty acids present in the oil reduced cell growth to a similar extent throughout the 
experiment From the standard curves produced m this study it was expected that both LA 
and oleic acid would inhibit growth of the SW480 cell line at concentrations of 51 and 22 
|ig/ml respectively It is therefore very likely that such high concentrations of LA and 
oleic acid m the unfermented oil greatly influenced the growth inhibitory effect of this oil
r
At the reduced concentration of 33 fig/ml the unfermented oil was significantly more 
potent compared with the synthetic mixture of fatty acids At this concentration of oil, LA 
was present at a concentration (20 ng/ml) which was seen to enhance cell growth and so 
clearly LA would not be expected to have the same inhibitory influence as was observed 
at the higher oil concentration Similarly, oleic acid (8 7 |ig/ml) would not have been 
expected to affect growth Fatty acid analysis determined total fatty acid content and did 
not distinguish between free and bound fatty acids Therefore, it may be possible that 
bound fatty acids present m the oil influenced SW480 cell growth differentially compared 
with the FFAs used to produce the synthetic representation of the oil
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It was noted that a small amount of both CLA isomers were produced m the unfermented 
oil suggesting that incubation conditions can result m the formation of CLA from LA 
However higher concentrations of these CLA isomers were present m the fermented oils, 
in particular the B breve NCFB 2258 fermented od At a concentration of 84 fig/ml, there 
was no significant difference between the growth inhibitory effect of the oils produced by 
the two Bifidobacteria strains However, both B lactis Bbl2 and B breve NCFB 2258 
fermented oils reduced growth compared with the unfermented oil after 24 h This led to 
an investigation as to which fatty acid components were responsible for the growth 
inhibitory effect of each individual oil
In the B lactis Bbl2 fermented oil, LA and oleic acid were present at similar 
concentrations and the data suggest that it was the combination of these two fatty acids
! i
that reduced cell growth when cells were treated with a concentration of 84 jxg/ml of B 
lactis Bbl2 fermented oil for 24 h and 48 h Addition of the c9? t\ 1 CLA isomer did not 
result in further cell growth inhibition However, this concentration of c9, t\ 1 CLA is very 
low (1 4 fig/ml) and has not been previously reported to inhibit SW480 cell growth It was 
apparent that the synthetic t9 ,t\l CLA isomer at a concentration of 1 jig/ml significantly 
reduced SW480 cell growth after 4 days incubation However addition of ¿9, t l 1 CLA (0 9 
fig/ml) to a mixture containing 33 jig/ml LA, 34 jig/ml oleic acid and 1 4 ng/ml c9, i l l  
CLA had a negligible additional effect thus demonstrating the relatively greater potencies 
of LA and oleic acid compared to CLA isomers
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At a concentration of 84 jig/ml, the growth inhibitory effect of the B lactis Bbl2 
fermented oil appeared to be due to the fatty acids present, however this was not the case 
at a concentration of 33 jag/ml When the concentration of the B lactis Bbl2 fermented oil 
was reduced to 33 (ig/ml of oil, it was significantly more potent (P<0 05) compared with 
fatty acid treatments which were representative of the B lactis Bbl2 fermented oil (l e 13 
\ig/ml LA, 13 ng/ml oleic acid, 0 5 fig/ml c9, i l l  and 0 4 fig/ml i9, i l l  CLA) (Figure 
3 8) This suggests that the fatty acid composition of the oil at this concentration was not 
solely responsible for the growth inhibitory effect observed on SW480 cells and suggests 
that there may be another component(s) present m this oil which was responsible for 
growth inhibition The effect of this component may be masked by the fatty acids present 
when used at a higher concentration, as the inhibitory effect of the B lactis Bbl2 
fermented oil at 84 jxg/ml appeared to be due to the fatty acids present
After 24 h, 48 h and 4 days incubation there was no significant difference between the B 
breve NCFB 2258 fermented oil (84 fig/ml) and the synthetic mixture of all four fatty 
acids This suggests that the combination of all four fatty acids was responsible for the 
growth inhibitory effect of the B breve NCFB 2258 fermented oil The data show that 
although LA was at a concentration which increases cell growth of the SW480 cell line, 
combimng it with oleic acid resulted in enhancing the growth inhibitory effect of oleic 
acid to 75% inhibition Similar results were observed by Takeshita, et al (1997) when in 
the presence of a high LA diet, oleic acid maintained its anticancer activity Addition of 
the c9, il 1 CLA isomer, which was present at a concentration of 20 (ig/ml, a concentration
8 9
which has been shown to be cytotoxic in this cell line after 48 h and 4 days (Figure 3 2C), 
appeared to have a strong influence reducing cell growth to 95%
However, when a lower concentration (33 ng/ml) of the B breve NCFB 2258 fermented 
oil was used to treat the cells for 4 days, there was no significant difference between this 
concentration and the higher concentration of 84 jig/ml Therefore, reducing the fatty acid 
content of the oils by over half did not significantly reduce the inhibitory effect of the oil 
The combination of the synthetic fatty acids representative ot the B breve NCFB 2258 
fermented oil at the lower concentration (33 fig/ml) did not reduce cell growth to the same 
extent as the oil itself suggesting that when used at the lower concentration of 33 \ig/m\ 
the fatty acids present may not have been solely responsible for the growth inhibitory 
effect observed As the bacterial strains used m this study are probiotic bactena it is likely 
that, like the B lactis Bbl2 fermented oil, another component could be contributing to the 
growth inhibitory effect
As already mentioned differences between the inhibitory effects of the oils and the 
synthetic mixture of fatty acids representing the oils may either be due to bound fatty acids 
or to the presence of other fermented products, in the case of B lactis Bbl2 and B breve 
NCFB 2258 fermented oils Such components may be vitamins such as vitamin K, a fat- 
soluble vitamin (reviewed by Cummings and Macfarlane, 1997) or butync acid, a short 
chain fatty acid which can be formed dunng bacterial fermentation Butync acid has been 
shown to inhibit colon carcinogenesis via increasing apoptosis m the colon (Hague, et a l , 
1993)
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At the higher concentration (84 (ig/ml) of the oils used, the effect of the fatty acids 
appeared to cancel out the effect of the other component, however when the concentration 
of the oils was reduced to concentrations which do not have a strong inhibitory effect on 
cell growth, the growth inhibitory effect observed may have been due to the other 
component having a stronger influence on cell growth inhibition This component would 
also be reduced as the concentration of the oil is reduced, however it may be possible that 
with the removal of the growth inhibitory effect of the fatty acids present its growth 
inhibitory effect is more obvious Another possibility is that it has an optimum 
concentration at which it displays its anticarcmogemc activity m a manner similar to that 
of the growth stimulatory effect of LA as observed in this study
It is clear that the oils produced by fermentation with the two Bifidobacterium strains
1 t
inhibited growth of the SW480 cell line The B breve NCFB 2258 strain produced 
significant amounts of CLA -  concentrations that have been shown previously and in this 
study to significantly inhibit SW480 cell growth When used at a lower concentration of 
33 jig/ml of the oils, there was still a similar potent inhibitory effect on SW480 cell 
growth This suggests that the presence of another component may be partially responsible 
for the growth inhibitory effect observed, as the synthetic fatty acid representations of the 
oils did not mimic the inhibitory effect of the bactenally transformed oils, unlike when the 
oils were used at a higher concentration of 84 jig/ml Further study is required to identify 
this component It may be beneficial to isolate the CLA produced by this bacterial strain 
and analyse its growth inhibitory effect mdependently It may also be beneficial to grow 
these probiotic strains with the cancer cells as attenuated Bifidobacterium are known to
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selectively multiply in tumours and inhibit growth (reviewed m Bermudes, et a l, 2002) 
Such a study would be difficult due to the differences in incubation requirements of the 
cancer cells and the Bifidobacteria, but would be very useful m further solving the 
relationship between the ability of probiotics to produce CLA and the anticarcinogemc 
activity of probiotic strains
3 4 1 Conclusion
As far back as 1907, it has been suggested that certain microorganisms can be beneficial 
to human health when mgested (Metchnikoff, 1907) However, the mechanisms used by 
many probiotics to benefit the health of the host are not fully understood, although some 
theories have been suggested in relation to anticarcinogemc activity (discussed m Section 
3 13) including inhibition of carcinogen producmg bactena, inhibit on of tumour 
formation and inactvaton of carcinogens The data from the study by Coakley, et al 
(2003) shows that B breve NCFB 2258 can produce high concentrations of CLA isomers 
that are shown m this study to inhibit cancer cell growth These data suggest that ingestion 
of B breve NCFB 2258 may exert ant carcinogenic effects However, further studies are 
needed to confirm any potental antcarcinogemc activity associated with mgeston of 
CLA-producmg Bifidobacteria in animal models of carcinogenesis
3 4 2 Summary
The objectve of this study was to analyse the anticancer activity of microbially produced 
conjugated linoleic acid (CLA) Lmoleic acid was fermented in the presence of two 
probiotic strains of B lactis Bbl2 and B breve NCFB 2258 The resulting oils contained
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1 6% and 23 9% c9, ¿11 CLA respectively and 1 1% and 1 9% ¿9, ¿11 CLA respectively 
At a concentration of 84 jig/ml, B lactis Bbl2 and B breve NCFB 2258 fermented oils 
significantly reduced growth of SW480, a human colon cancer cell line, in a time 
dependant manner compared with an ethanol control An unfermented oil extract 
containing 0 8% c9, ¿11 CLA and 0 5% f9, ¿11 CLA, 61% LA and 26% oleic acid also 
reduced cell growth Synthetic models of the oils containing their four main constituent 
fatty acids, LA, oleic acid, c9, i l l  CLA and ¿9, ¿11 CLA at a concentration of 84 |ig/ml 
reduced growth to a similar extent as the oils suggesting that the fatty acid composition of 
the oils had a major inhibitory influence on growth The c9, ¿11 CLA isomer was at a 
concentration of 20 ¿ig/inl in the B breve NCFB 2258 fermented oil (84 jig/ml) When 
added to a combination of LA and oleic acid, the resulting growth inhibition relative to 
control was 95%, compared with 75% inhibition when cells were mcubated with a LA- 
oleic acid mixture The ¿9, ¿11 CLA was at a concentration of 1 6 jig/ml in the B breve 
NCFB 2258 fermented oil (84 ng/ml) Though inhibitory effects of this isomer were not 
apparent when co-mcubated with inhibitory concentrations of oleic acid and c9, ¿11 CLA, 
this study demonstrated for the first time that ¿9, ¿11 CLA alone was more potent than c9, 
¿11 CLA, reducmg cell growth by 14% (P<0 01) at a concentration of 1 jig/ml and as 
much as 43% (P<0 001) at a concentration of 10 jig/ml Upon reducing the concentration 
of the oils to 33 jxg/ml the synthetic fatty acids did not inhibit cell growth to the same 
extent as the oils, suggesting that another growth inhibitory factor may be present in the 
oils
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CHAPTER 4
AN I N V E S T I G A T I V E  STUDY TO 
E N R I C H  M I L K  FAT CLA IN H I G H  
C L A - P R O D U C I N G  COWS
4.1 Introduction 
4 1 1  Milk Lipids
Triglycerides are the major class of lipid found in milk fat making up approximately 
98% of the total fat (Table 4.1) The primary fatty acids found in milk are long cham 
fatty acids -  Cm o (myristic), C\e o (palmitic), Cis o (steanc), Ci8 1 (oleic) and the mmor 
fatty acids are short chain C4 o (butyric), C6 o (caproic), Cg o (caprylic), Cio o (capnc) 
(reviewed in Christie and Clapperton, 1982, Parodi, 1983, Timmen and Patton, 1988, 
Jensen, et a l, 1991, Jensen, 2002)
Table 4 1 Milk fat composition (reviewed m Jensen, 2002)
Lipid Class % Total Milk Fat
Tnglycendes 98
Diacylglycendes 0 25-0 48
Monoacylglycendes 0 02-0 04
Phospholipids 0 6-10
Cholesterol 0 2-0 4
Glycolipids 0 006
Free fatty acids 0 1-0 4
Milk fatty acids can be synthesised by either de novo synthesis or by ruminal 
fermentation and earned to various parts of the body via the circulatory system 
(Figure 41) (reviewed in Barber, et a l , 1997) In the rumen, glycolipids, 
phospholipids and triglycerides consumed m the diet undergo lipolysis resulting in the 
formation of FFAs, which are isomerised and hydrogenated by the activity of ruminal 
microorganisms (reviewed in Chilliard, et a l , 2000) In the case of LA (Cl 8 2), 
hydrogenation by an isomerase produced by Butyrivibrio fibrisolvens leads to the 
formation of fatty acids such as VA (C l8 1 t i l )  and following further hydrogenation, 
steanc acid (C l8 0) The fatty acids formed and the pathways occumng depend on the 
microbial ecosystem in the rumen (Keeney, 1970)
95
Undigested
Bacterial  ►bacterial
Phospholipids Lipids
Bacterial —  
Phospholipids
Free Fatty adds
Fatty
Fatty Acids
BLOOD
(General
circulation)
Fatty Acids
Triglycerides
ADIPOSE TISSUES MAMMARY GLAND
RUMEN INTESTINE FECES
INTESTINAL
CELLS
LYMPH
VESSEL
PORTAL
BLOOD
(To the liver)
Grains
Forage
RUMINAL
WALL
r-* carbohydrate 
i metabolism 
Glucose 
LIVER t  Ketones < 
Glycerol
►  Triglyceride 
storage
G-rich LP
Glucose
■ Energy |
1  " T  Glycerol
Ik Fat M------------1
Glycerol
Acids T G ^ L P G jy “ 1101 J
Fatty A ciÈ—i r ~  G|ucose 
I I  Glycerol 4 I (Energy) |
Mill
(Long chains)
Figure 4.1 Summary o f bovine lipid metabolism (Wattiaux and Grummer, 1997)
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Lipids leaving the rumen consist of 85-90% saturated FFA and 10-15% phospholipids 
Palmitic acid and steanc acid make up the majority of the saturated FFAs and are 
bound to particles such as microbial or feed particles FFAs leaving the rumen are 
available for absorption into the circulatory system and incorporation into milk fat
De novo synthesis takes place in the cytoplasm of the mammary epithelial cell and 
leads to the formation of short and medium chain fatty acids In ruminant animals, 
cellulose and hemicellulose are fermented by rummal microorganisms to produce 
volatile acids consisting mamly of acetic, propionic and butyric acid, acetate and (3- 
hydroxybutyrate (BHB) being the carbon sources utilised in fatty acid synthesis Two 
enzymes are involved in this process -  acetyl-CoA carboxylase (a rate limiting 
enzyme) and fatty acid synthetase (required for elongation of fatty acid chains) 
(reviewed m Barber, et a l , 1997) High concentrations of propionate (achievable by 
feeding a high concentrate diet) can lead to reduced milk fat (reviewed in Doreau, et 
a l , 1999) Very low density lipoproteins (VLDL) present m the blood, are produced m 
the liver and intestine and consist of 90-95% of lipids (55-60% triglycerides), and the 
remainder consisting of a protein outer surface Lipoprotein lipase (LPL) hydrolyses 
VLDL triglycerides in the mammary capillaries The resulting FFA, 
monoacylgylcendes, diacylglycendes and glycerol can be absorbed by the mammary 
epithelial cells and are available for synthesis of triglycerides In the mammary gland, 
triglycerides are synthesised at the cytoplasmic surface of the smooth endoplasmic 
reticulum The FFA are then estenfied to the hydroxyl group of glycerol units resulting 
in triglycerides Of the fat present m milk, approximately 50% comes from fatty acids 
produced in the mammary gland (reviewed in Chilhard, et a l , 2000) As they are 
produced, the triglycerides coalesce to form droplets of lipids which are released mto
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Vthe cytoplasm These may come together to form larger droplets, they may be released 
from the cells as small milk fat droplets or may combine with cytoplasmic droplets to 
form cytoplasmic lipid droplets Eventually large milk fat droplets are released at the 
apical surface of the cell (reviewed in Mather and Keenan, 1998)
4.1.2 Rummal Production of Milk Fat CLA
The c9, tl 1 CLA isomer is an intermediate m the biohydrogenation of LA to stearic 
acid (Kepler, et a l , 1966) During microbial hydrogenation LA is first isomensed to 
c9, t l 1 CLA by LA isomerase of rumen bacteria such as Butyi ivibrio fibnsolvens 
(reviewed m Harfoot and Hazlewood, 1988) The c9, t l 1 CLA is quickly hydrogenated 
to VA by reductase enzymes and this is then further hydrogenated to form steanc acid 
While some of the c9, tl 1 CLA is believed to be absorbed directly, the major source of 
milk fat CLA is due to the activity of mammary A9-desaturase activity which converts 
VA to c9, 111 CLA m the mammary gland (Bickerstaffe and Anmson, 1970, 
Bickerstaffe and Johnson, 1972, Kinsella, 1972, Ward, et a l , 1998) The A9- 
desaturase results in a second point of desaturation at carbon 9 (C9) of VA (C18 1 t l 1) 
in the cis configuration, producing c9, t l 1 CLA The mammary glands appear to be the 
major site of endogenous synthesis of CLA m ruminants (Bickerstaffe and Anmson, 
1970, Kinsella, 1972) A number of factors indicate this In the first instance, c9, tl 1 
CLA appears to be a transient intermediate in the rumen, unlike VA which 
accumulates There appears to be a linear relationship between VA and c9, t l 1 CLA 
which remains constant across a range of diets suggesting a precursor/end-product 
relationship (reviewed in Grimari and Bauman, 1999) Abomassal infusion of VA, the 
substrate for A9 desaturase, resulted in a 40% increase m milk fat CLA, while sterculic 
acid, a A9 desaturase inhibitor, dramatically reduced milk fat c9, i l l  CLA content
9 8
(Corl, et al 1998) Endogenous synthesis of CLA is estimated to account for 78-80% 
of the total c9y t\ 1 CLA in milk fat (Corl, et a l , 2001, Lock and Gamsworthy, 2002) 
The fact that a 100% reduction m CLA concentrations due to sterculic acid was not 
observed by Corl, et al (1998) indicates that endogenous synthesis is not the sole 
source of CLA
Although c9, i l l  is the predominant CLA isomer produced during microbial 
biohydrogenation of LA, other rummal micro-organisms appear to have an ability to 
produce the ¿10, cl2 CLA isomer, although these micro-organisms have not been 
identified (Fellner, et a l , 1999) It appears that this isomer forms as a result of 
biohydrogenation of transA 0-octadecenoic acid due to rummal bacterial metabolism 
(Griinan and Bauman, 1999) It is unclear if humans possess the A12 desaturase 
enzyme A study by Adlof, et al (2000) did not detect it within a detection limit of <2 
ng FAME/ml plasma, however it was suggested that there is a possibility that humans 
may possess such an enzyme Therefore rummal biohydrogenation is the most likely 
source of the ¿10, cl2 CLA isomer
Kim, et al (2000) showed that B fibrisolvens A3 8 produced high concentrations of 
CLA m the presence of high concentrations of LA (>350 jiM) High concentrations of 
LA resulted in incomplete hydrogenation However, when this occurred the cells were 
no longer viable This suggests that CLA is not a normal end product of these cultures 
and the CLA in milk fat is the result of another process i e endogenous synthesis
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4.1.3 Manipulation of the Diet to Enhance Milk Fat CLA
i
Dairy products are the mam source of CLA in the human diet (discussed in Chapter 
1) Due to the many health benefits associated with CLA, such as activity against 
carcinogenesis, atherosclerosis and diabetes (reviewed in Belury, 2002), it is of interest 
to increase CLA concentrations m bovine milk It has been known since 1935 that 
dairy products contain fatty acids with conjugated double bonds (Booth, et a l , 1935) 
when butter fat exhibited spectrophotometnc absorption at 230nm Parodi (1977) 
demonstrated that c9, t\ 1 CLA is the predominant CLA isomer m milk fat
There are many factors which influence the fatty acid composition of milk and there 
tends to be a wide variation in the c9, t\ 1 CLA content of milk A number of factors 
have been implicated m this such as, dietary supplementation (reviewed in Chilliard, et 
a l , 2001), animal age (Lai and Narayanan, 1984, Stanton, et a l , 1997), stage of 
lactation (Lai and Narayanan, 1984, Stanton, et a l , 1997) and ammal breed (Lawless, 
et a l , 1999, White, et a l , 2001) Because production of CLA involves a microbial 
biohydrogenation pathway and mammary A9-desaturase activity, there are two 
possible approaches used to enrich milk fat CLA CLA concentrations are high m the 
milk of cows on pasture (reviewed m Bauman, et a l , 2000a) compared with cows on 
conserved forages Lmolemc acid is the principal fatty acid in fresh pasture and 
biohydrogenation of LA in the rumen does not result in CLA as an intermediate 
However, VA is produced during this process and this fatty acid can be converted to 
c9, t\ 1 CLA via A9 desaturase activity (Griinan et a l, 2000, Santora et a l , 2000) 
Further enhancing the concentration of substrates for the biohydrogenation process is 
one possible approach to enhancing milk fat CLA The second approach is to modify 
the activity of rummal microorganisms involved in the biohydrogenation process via
optimisation of their environmental conditions (Gmnan and Bauman, 1999) Animal 
fat (tallow), plant oils (soybeans, linseed, rapeseed and sunflower), fish oil in addition 
to pasture feeding have all been used successfully to alter the fatty acid profile of 
bovine milk and ennch milk fat CLA
Table 4 2  Summary of effect of dietary variations on CLA content of milk fat (taken from Jensen, 2002)
Dietary Factor Content of CLA in milk fat
a Lipid substrate
Unsaturated vs saturated fat 
Plant oils
Type of plant oil
Level of plant oil
Ca salts of plant oils 
High-oil com plant seeds 
Raw seeds 
Processed seeds
High-oil com gram and silage 
Animal fat by-products
b Modifiers o f rumen environment 
Forage Concentration ratio
Nonstructural carbohydrate 
level
Restricted feeding
Fish oil/fish meal
Marine algae 
Ionophores
Dietary buffers
c Combination of a and b 
Pasture
Growth stage of forage 
CLA supplement
Increased by addition of unsaturated fa t(Gnman etal 1998a) 
Increased with oils high in unsaturated fatty acids(Tesfe
eta l 1991 Dhunan,e ta l  2000 Choumard etal 1998a Kelly etal 1998a)
Dose-dependent increasecresfe e,cd 1991 McGuire e,a‘ 1996
Dhunan, et al 2000)
Increased (Ch0Umaid>e' a/ (1998fl)
No effect Caiman, ei a/ 2000 Choumard, et al 1998a)
Increased (Stanton’et al 199^  Choumard etal 1998a Lawless etal 1998} 
Dhunan, etal 1999)
Mimmal effect(Dhunan’et al 19965 Choumard et al 1998a)
Minimal effect(Choumard etaI 1998a)
V a r i a b l e  e f f e c t  ^ ian® e ta  ^ 1996 Choumard, et al 1998b Gninan e ta l 
1998a)
M i n o r  e f f e c t  ^oum ard , et l " 8 b  Solomon, e ta l  2000)
V a r i a b l e  e f f e c t ^ unmen^ P attot  ^ ^988 Jiang e ta l  1996 Stanton et
al 1997)
I n c r e a s e d  et a  ^1996 Choumard, et al 1998a Chilhard, et al
1999)
Increased(FranUm’e1 d 1999>
V a r i a b l e  e f f e c t  et al *996 Choumard, et al 1998b Sauer e ta l
1998)
Little effect with sufficient fibre(Chomnard elal 1998b)
Higher than on conserved forages !-TlIll:nC!1 imd :‘’a!!on. 1588
Dhiman etal 1996 Zegarska etal 1996 Jahreis etal 1997 Prechtand 
Molkentin 1997, Kell) etal 1998b)
Increased with less mature forage(Choumard e,al 1998b) 
Dose-dependent increase(LoorandHerbein’ 1998 Choumard etal
1999a Choumard, et al 1999b Giesy etal 1999)
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It is possible to further enhance the effect o f lipid supplements by processing the 
oilseed to make the oil more readily available for conversion to CLA (reviewed in 
Chilliard, e t  a l ., 2000).
Extensive study has been carried out on the effects o f  dietary supplementation on the 
fatty acid profile and the CLA content o f milk fat. The results o f these studies are 
summarised in Table 4.2 and will be discussed in detail below.
4.1.4 Dietary Supplementation with Plant Oils to Elevate Milk Fat CLA
Plant oils rich in LA such as cottonseed, soyabean, sunflower and safflower when fed 
to lactating cows have been shown to enhance the CLA content o f  milk fat. In addition, 
plant oils rich in linolenic acid, e.g. linseed oil (Kelly, e t  a l ., 1998a), and rapeseed oil 
rich in oleic and linoleic acid (Stanton, e t  a l ., 1997) have also been shown to enhance 
CLA concentrations when fed to lactating cows.
c is -6, c/5-9, c/5-12 c/5-9, c/5-12, c/5-15
(y-linolenic acid)1 1(a-linolenic acid)
Isomérisation of the cisAl
double bond
c/5-6, c/5-9, t r a n s -12 c/5-9, t r a n s - 12, c/5- 15
(conjugated octadecatrienoic acid) (conjugated octadecatrienoic acid)
c/5-6, t r a n s -11 
(octadecadienoic acid)
t r a n s  A l , c/5-15 
(octadecadienoic acid)
t r a n s A l  
(vaccenic acid)
C18:0
(stearic acid)
Figure 4.2 Biohydrogenation of y- and a-linolenic acid
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Linolemc acid, when biohydrogenated, leads to the formation of VA (C l8 1 i l l ) ,  
although c9, i l l  CLA is not formed during this biohydrogenation pathway (Figure 
4.2)
Following absorption of VA, this fatty acid is converted to CLA by the action of A9- 
desaturase in the mammary gland (Harfoot and Hazlewood, 1988, Gninan, et a l , 
1998a) Kelly, et al (1998a) demonstrated that sunflower oil (rich m LA) was more 
effective at increasing CLA concentrations in milk fat compared to peanut and lmseed 
oil Feeding sunflower oil to cows housed indoors increased CLA concentrations to 
24 4 mg/g milk fat compared to 13 3 mg/g milk fat and 16 7 mg/g milk fat for peanut 
and lmseed oil, respectively This study suggested that dietary supplementation of the 
CLA precursor LA resulted in the largest increases in milk fat CLA Sunflower oil had 
much higher LA content (69%) compared with lmseed oil (15 4%) Lock and 
Gamsworthy (2002) demonstrated that when linoleic and/or linolemc acid were 
present m the diet at high concentrations, milk fat c9, t l  1 CLA was highest Olive oil, 
lmseed oil, rapeseed oil, soya oil and sunflower oil were combined at different 
concentrations resulting in four diets varying in linoleic and linolemc acid 
concentrations which were fed to lactatmg cows It was demonstrated in this study that 
80% of the c9, ¿11 CLA was produced via conversion of VA by stearoyl CoA 
desaturase in the mammary gland (Lock and Gamsworthy, 2002)
Feeding cows a diet rich in full fat soybean and ground full fat rapeseed (FFR) 
significantly increased CLA in the milk produced, to concentrations of 19 1 and 23 7 
mg/g fat respectively (Lawless, et al 1998) It may have been that the soybean yielded 
lower CLA concentrations, because it was not as available to ruminal microrgamsms
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as was the ground rapeseed due to heat treatment Not only does the oil source and 
quantity affect the content of CLA in the milk fat but also the processing of the oil 
supplemented (Dhiman, et a l , 1999, Murphy, et a l , 1990, Lawless, et a l , 1998) and 
the level of oil present Dhiman, et al (2000) fed 180 g/kg raw cracked soybean, 180 
g/kg roasted cracked soybean, 22 g/kg linseed oil and 44 g/kg linseed oil to dairy cows 
and found that feeding raw soybeans had no effect on the CLA content of the milk fat, 
while feeding roasted soybeans resulted in a doubling of CLA concentrations 
However as Lawless, et al (1998) demonstrated roasting of the oil source may not be 
as effective as grinding in providing a substrate for ruminal biohydrogenation It may 
also be due to the fact that rapeseed has been found to provide a more suitable 
substrate for ruminal biohydrogenation (Lawless, et a l , 1998) Extrusion involves 
forcing feed through metal holes to break it up, releasing its components, including oil 
The advantage of this process with regard to elevating CLA concentrations in milk fat 
is that the oil becomes more readily available for microbial biohydrogenation in the 
rumen Feeding extruded soybeans (ground full fat soybeans were heated to 138-149°C 
for 1-3 mm) significantly increased CLA concentrations m milk fat compared to a diet 
without extruded soybeans (Solomon, et al 2000), a demonstration of the beneficial 
effect of processing soybeans Heat-processing soybeans produced similar increases in 
milk fat CLA as extrusion of soybeans (Chouinard, et a l , 1998a) A soybean oil 
content of feed, equivalent to 5 and lOg/kg dry matter (DM) produced a CLA content 
of 7 5 and 7 6 g/kg total fatty acids respectively, however on increasing the soybean oil 
concentration to 20 and 40 g/kg DM the resulting CLA contents were 14 5 and 20 8 
g/kg total fatty acids respectively (Dhiman, et al 2000) A supplemental gram diet 
containing mechanically extracted soybean meal as opposed to solvent extracted 
soybean meal, increased concentrations of c9, t\ 1 CLA in milk fat (Loor, et al 2002)
1 0 4
again demonstrating the differential effects of different oil processing systems on CL A 
concentrations in milk fat The effect of processing on CLA enrichment of milk fat was 
again demonstrated when different processing systems were used to process the 
soybeans increased CLA concentrations in milk fat by 2 to 3-fold compared to a 
control diet which consisted of raw ground soybeans The processes used were 
extrusion, micromzing (a short time, high temperature process using humidity, 
temperature (infra-red energy) and mechamcal pressure) and roasting (cooking with 
dry heat) of the soybeans (Chouinard, et a l , 2001)
4 1 5  Marine Oils
Marine oils, including both oil from fish and marine plants, have been shown to have 
an ability to elevate CLA concentrations m milk fat when included in the diet 
(reviewed m Chilliard, et a l , 2000 and 2001) Fish oils are already known for their 
beneficial health effects due to the presence of long chain PUFAs namely 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) The mechanism by 
which CLA is enriched is unknown, but increases in nominal and milk VA 
concentrations has been observed (reviewed in Chilliard, et a l , 2000) One theory is 
that reduction of VA is prevented by inhibition of the growth of rumrnal bacteria 
involved in this process due to the presence of long chain PUFAs m the manne oil 
(Gniann and Bauman, 1999) It has been observed that supplementing the diet with 
fish oil reduces the fat content of milk (Doreau, et a l , 1999, Abu-Ghazaleh, et a l , 
2001)
There have been a number of studies on the effect of marine oils on CLA content of 
milk fat (reviewed m Chilliard, et a l , 2001) One such study was undertaken by Jones,
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et al (2000) in which an increase in milk fat CLA and VA was demonstrated after 
dietary supplementation with 3% tallow fish oil mixture, however there was no effect 
on milk yield or composition The optimum concentration of dietary fish oil resulting 
in maximal increases in milk fat CLA was demonstrated to be 20 g/kg of DM with no 
additional increase m milk fat CLA observed with a further increase in fish oil 
concentrations (Donovan, et a l , 2000, Baer, et a l , 2001, Chouinard, et a l, (2001) 
The concentrations of fish oil can be decreased by partial substitution with dietary 
plant oils Incorporation of menhaden fish oil at a concentration of 20 g/kg into the diet 
of cows increased milk fat CLA concentrations to 23 g/lOOg fatty acids compared to 
2 17 g/lOOg fatty acids for a mixture of 10 g/kg menhaden fish oil and 10 g/kg fat from 
extruded soybeans (Ramaswamy, et a l , 2001a) Abu-Ghazeleh, et al (2001) 
demonstrated that dietary supplementation with fish oil can be more effective than 
plant oils m elevating milk fat CLA, when an increase from 0 39 g CLA/lOOg fatty 
acids to 0 72 g CLA/lOOg fatty acids was observed due to fish oil supplementation 
Other studies have demonstrated higher concentrations c9, t\ 1 CLA and VA in milk 
fat after fish oil supplementation compared with soybean oil supplementation 
(Whitlock, et a l , 2002)
It is also possible to enhance milk fat CLA using algae as a supplement (Franklin, et 
a l , 1999) A species of marine algae, Schizochytrium sp , is a rich source of long chain 
n-3 fatty acids The diet was supplemented with 910 g of these algae either protected 
by coating with xylose or unprotected Both protected and unprotected algae led to 
similar increases of 6 to 7-fold m milk fat CLA compared with the control
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It is also important that the use of fish oil as a dietary supplement does not adversely 
affect the sensory qualities of milk or dairy products produced using the milk No 
differences in the sensory qualities of milk and butter were observed after a three- 
month storage period (Ramaswamy, et a l , 2001a) There was no difference between 
control milk and milk from the 20 g/kg fish oil diet according to consumer evaluation 
(Ramaswamy, et a l , 2001b)
4 1 6  Animal Fats
Another supplement used to enrich milk fat is animal fat (also known as tallow) 
(Palmquist, 1988) Animal fat is rich in long chain saturated fatty acids such as 
palmitic (23-27%) and steanc acid (14-29%), being low m LA at 1-5% (reviewed in 
Chilliard, et a l , 2001) Enhancing milk fat CLA using animal fat as a supplement is 
not as successful as the other dietary supplements discussed above This is due to the 
fatty acid profile of annual fat, which is low m PUFAs Only low increases in CLA 
(increased from 0 2 to 0 5%) and VA (from 0 9 to 1 6%) were obtained, after dietary 
supplementation with 40-50 g/kg tallow (Pantoja, et a l , 1996, Chouinard, et a l , 
1998a) Tallow supplemented at 0, 20 and 40g/kg of the diet DM did little to increase 
VA concentrations in milk (Onetti, et a l , 2001) It has been demonstrated that tallow 
can reduce saturated fatty acids from C6-C16, while increasing C l8 0 and C l8 1 in 
milk fat (reviewed in Chilliard, et a l , 2001) There still remains the question of safety 
regarding the use of animal fat in foodstuffs Due to the risk of BSE associated with 
animal products it is important that all traces of protein be removed from the fat before 
it is used as a dietary supplement This is possible although there is the risk of 
contaminants such as hair fragments remaining (Padley, et a l , 1994, Palmquist, 1988)
10 7
The fatty acid content of pasture around the world vanes greatly but is typically 1-3% 
fat Tropical climates produce grass containing 150-400 g/kg a-linolemc acid, while in 
temperate climates a-lmolemc acid accounts for 550-650 g/kg of the fatty acids, the 
grass containing 10-30 g/kg fat Fatty acid content of pasture vanes throughout the 
year reaching its highest in the spnng and autumn months (Kudzal-Savoie, 1965, 
Bauchart, et a l , 1984) When cows are fed on pasture the concentrations of oleic acid 
increase and of palmitic acid decrease (reviewed in Chilhard, et a l , 2001) A number 
of studies have demonstrated that pasture feeding can greatly increase milk fat CLA 
(Timmen and Patton, 1988, Stanton, et a l , 1997, Kelly, et a l , 1998b, Agenas et a l , 
1999, Dhiman, et a l , 1999) The LA m grass is extensively hydrogenated in the rumen 
leading to the formation of VA and m turn c9, t\ 1 CLA The effect of pasture on c9, 
t\ 1 CLA synthesis is also attributed to its influence on ruminal microflora and in turn 
biohydrogenation (Gninari and Bauman, 1999) A sharp increase m conjugated dienes 
was observed when cows were turned out to pasture after winter-feeding on grass 
silage, hay and beets, while no further increase was observed after 5 days (Kudzal- 
Savoie and Kudzal, 1961, Kudzal-Savoie, 1965) Both VA and CLA were increased 
when cows were put on pasture (Lawless, et a l , 1999) Although CLA concentrations 
increase with grass allowance (Stanton, et a l , 1997) they are not affected by the 
matunty of the grass (Gninan, et a l , 1998b) Stanton, et al (1997) found that 20 kg 
grass/cow per day resulted in higher milk fat CLA concentrations than 16 kg grass/cow 
per day m a 19 week feeding tnal Kelly, et al (1998b) and Dhiman, et al (1999) both 
demonstrated that pasture alone resulted in higher CLA concentrations in milk than 
when combined with other dietary components such as cottonseed, legume hay, 
roasted soybeans or alfalfa hay Likewise, milk from pasture (crabgrass -  Digitaria
4.1 7 Pasture
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sanguinahs) fed cows contained proportionally 0 83 more c9, t\ 1 CLA than cows fed a
*
mixed diet which included com, silage, alfalfa silage, ground com, soybean meal and 
whole cottonseed (White, et a l , 2001) Similar results regarding CLA content of intra­
muscular fat of steers were observed by French, et al (2000) It is also clear that the 
variety of grass used to supplement the diet is another factor which influences the CLA 
content of milk fat Loyola, et al (2002) demonstrated the effect of grass using four 
varieties of ryegrass, these were Spelga and Portstewart (both diploid), and Napoleon 
and Millennium (both tetraploid) with different heading dates Although the four 
varieties had similar linoleic and lmolenic acid contents, milk fat c9, t\ 1 CLA content 
varied when a diet of Spelga or Napoleon was administered Millennium and 
Portstewart resulted in 1 72 g/100g FAME and 1 71 g/100g FAME in the milk 
respectively Intermediate concentrations (1 54 g/100g FAME) were achieved by 
feeding with Spelga, whereas Napolean produced the lowest milk fat CLA 
concentrations of 1 35 g/lOOgFAME
Another factor affecting the CLA content of milk fat is the forage to concentrate ratio 
CLA and VA concentrations in milk fat can be increased with a diet which has a low 
forage to concentrate ratio compared to a diet with a high forage to concentrate ratio 
(Chouinard, et a l , 1998b) This low forage to concentrate ratio diet led to reduced 
ruminal pH Similar results were observed by Kalscheur, et al (1997) in a study where 
buffer was added to the low fibre diet Addition of the buffer to the diet led to 
increased pH and a reduction in production of /r<ms'-octadecenoic acids Granan, et al 
(1998a) found that a diet with a low forage to concentrate ratio led to enrichment of 
milk fat with the /10, c\2 CLA isomer
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Fats and oils can be protected against biohydrogenation by rumen microorganisms 
Physical protection involves heat-treating oilseeds The high temperatures alter the 
protein matrix around the fat droplet, the result being protection agamst 
biohydrogenation (reviewed m Kennelly, 1996) Similarly, whole oilseeds are 
protected agamst biohydrogenation due to the presence of an intact hull The level of 
protection provided depends on the size, physical and chemical properties of the hull 
Chemical protection can be achieved by emulsification or encapsulation (Kim, et a l , 
2000) in a protein matrix, one example being the treatment of a protein with 
formaldehyde In vitro studies have demonstrated that this technology can provide as 
much as 85% protection, whereas a maximum of 65% protection has been shown in 
vivo (Ashes, etal 1979, 1992, Storry, et al 1980) This reduced effectiveness is due to 
physical breakdown of the protective protein matrix by mastication and digestive 
processes within the rumen Another form of chemical protection is the formation of 
calcium (Ca) salts An mcrease in milk fat CLA of 3 to 5-fold after supplementing the 
diet with Ca salts of canola, soybean, and linseed oil has been achieved (Chouinard, et 
a l , 2001) This was most likely due to breakdown of the protection mechanism within 
the rumen
Although one of the aims of supplementmg the diet with plant oils is to enhance milk 
fat CLA, protection of the substrate against ruminal digestion seems contradictory -  
even though Chouinard, et al (2001) showed otherwise It would, however, appear 
more advantageous to protect CLA supplements agamst such activity In an in vitro 
study, 80-90% of unprotected CLA was hydrogenated under anaerobic conditions at 
38°C for 24 h Encapsulating the CLA in a matrix of protein resulted in only 30%
4.1.8 Protected Oils
no
hydrogenation of CLA isomers under the same hydrogenation conditions, with 70% 
protection achieved (Gulati, et a1,2000)
4 1.9 Effect of Processing on the CLA Content of Milk
Not only is it of interest to enrich milk with CLA but also it is important that this 
beneficial component is not negatively altered during processing of the milk fat It has 
been demonstrated that the means by which dairy products are processed can lead to 
wide variation in CLA content (Ha, et a l , 1989, Chin, et a l , 1992, Parodi, 1994, Lin, 
et a l , 1995) Microbial fermentation dunng cheese ripening has led to increases m 
CLA content of the final product (Aneja and Murthi, 1990, Lin, et a l , 1999b) 
However, such changes have not been observed m yoghurt production and it has been 
suggested that it is the dietary supplement used to produce the CLA enriched milk that 
will determine the CLA content of yoghurt rather the processing of the product 
(Shantha, et a1, 1995, Boylston and Beitz, 2002) CLA enriched milk was produced 
following dietary supplementation of a 13 5% soybean meal diet with 12% full fat 
extruded soybeans or full fat extruded cottonseed with a 109% and 77% increase 
respectively m milk fat CLA compared with milk fat from the control diet Production 
of Mozzarella cheese from this CLA enriched milk did not alter CLA concentrations 
(Dhiman, et a l , 1999) Bauman, et al (2000b) produced CLA enriched butter after 
feeding a low forage diet supplemented with sunflower oil The result was the 
production of milk with increased concentrations of CLA It was necessary to collect 
the milk for the study over the first few days from the cows that produced the highest 
concentrations of CLA as the increased concentrations of CLA were transient and 
declined over a three-week period The resulting butter had CLA concentrations 7-fold
i l l
greater than that of the control butter with the c9, t\ 1 isomer being the most abundant 
isomer at 91%
4 1.10 Objective of Experiment
Previously it has been demonstrated that after 18 days feeding of ground FFR c9, ¿11 
CLA concentrations m milk increased to 31 8 mg/g fat compared with 13 4 mg/g fat in 
the milk of control cows on the unsupplemented diet (Lawless, et a l , 1998) Stanton, 
et al (1997) also demonstrated that a diet supplemented with high concentrations 
(1650 g/day per cow) of FFR resulted m higher milk fat CLA than diets consisting of 
pasture alone or containing lower concentrations (825 g/day per cow) of FFR
There is great variation in milk fat CLA concentrations between individual cows, with 
concentrations as low as 2 mg/g fat and as high as 30 mg/g fat being observed 
(Lawless, et a l , 1998, Jiang, et a l , 1996) This variation may be due to differences in 
the expression of A9-desaturase between cows, although this has yet to be proven It 
would therefore be beneficial to select cows with a natural ability to produce high 
concentrations of CLA in combination with the manipulation of the diet by 
supplementation with plant oil with a view to further elevate milk fat CLA
In this study, cows were selected as low or high CLA producing animals These were 
then supplemented with FFR to determine (a) the response of cows with different 
CLA-producmg abilities on a control diet of pasture only and a diet supplemented with 
rapeseed and (b) the period of time required to achieve a maximum concentration of 
CLA due to dietary supplementation
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4 2 Materials and Methods 
4 21  Materials
The supplemental feed (Pura 42™) was purchased from J W Green and Co L td , Cork, 
Ireland Pura 42™ is a blend of whole rapeseed and pulses which is processed using 
“fluidised bed” cooking technology The blend temperature is raised to 125°C and then 
steam cooked for approximately 20 min at over 100°C The cooked product is then 
ground and pelleted Lmoleic acid (LA) and Tndecanoic acid (C l3 0) (99% pure) were 
purchased from Sigma-Aldnch Ireland L t d , (Dublm) Pure c9, f l l  and /10, cl2  CLA 
isomers were obtained from Matreya (Pleasant Gap, PA) Methanolic HC1 (12% v/v) 
was obtained from Supelco Inc (Bellefonte, PA) Hexane, methanol and chloroform 
were purchased from LabScan Analytical Services L td , Umt T26, Stillorgan Industrial 
Park, Co Dublm, Ireland
4.2 2 Experimental Design
The experiment was a 2 (high and low CLA producing cows) x 2 (unsupplemented and 
supplemented) factorial design Milk from 59 individual cows was analysed for CLA 
content and subsequently 40 cows (16 autumn-calvers per treatment and 4 spring- 
calvers per treatment) were selected and divided into two groups of high and low CLA 
producers These two groups were further divided into cows fed a control diet and 
cows fed a diet supplemented with 3 3 kg/day Pura 42™ Supplementation (8 autumn- 
calvers and 2 sprmg-calvers per diet) contmued for 8 weeks
4 2 3 Collection of Milk Samples
Samples were taken at the evening milking for the first ten days of the tnal beginning 
the day prior to commencing dietary supplementation (day 0) These samples were
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composited according to yield into 1 sample per treatment group for analysis A sub­
sample was removed from the day 8 sample of each cow and analysed individually It 
was anticipated that differences m c9, t i l  CLA concentrations would be evident by 
day 8 of supplementation based on previous observations (Lawless, et a l , 1998)
4.2 4 Fatty Acid Analysis of Milk Fat
Milk fat samples were obtained by collecting the cream by centrifugation at 1,000 x g 
for 20 mm at 4°C Following overnight storage at -18°C the cream was heated to 60°C 
for 10 min and centrifuged at 1,600 x g for 7 mm The top layer (milk fat) was 
removed and stored at -20°C prior to methylation (Murphy, et a l , 1990) Milk fat was 
methylated using acid-catalysed methylation as described by Stanton, et al (1991) 
with reference to the internal standard Cn o Milk fat (30 mg) and C13 0 (1 5 mg/g fat) 
were resuspended m 12 ml of 12% HC1 (v/v) in methanol and incubated at 60°C for 20 
mm, vortexing every 10 mm The sample was then washed with 2 ml water saturated 
hexane and 5 ml hexane, vortexed for 30 sec followed by centrifugation at 1,000 x g 
for 5 mm The top layer containing the FAMEs was removed and washed with 2 ml 
water saturated hexane, vortexed and centrifuged at 1,000 x g for 5 mm The top layer 
was removed and 0 5 g anhydrous sodium sulphate was added, vortexed for 5 sec and 
allowed to stand for 1 hr The top layer was then removed and diluted for GC analysis 
(150 j^ L sample and 850 ¿iL hexane) Separation of the FAME was performed on a 
Chromopack CP Sil 88 column (100 m x 0 25 mm i d ,  0 20(im film thickness, 
Chromopack, Middleburg, Netherlands) using a Vanan 3400 GLC (Varian, Walnut 
Creek, CA, USA) fitted with a FID Helium was used as the carrier gas at a pressure of 
32 7 psi The injector was held at an initial temperature of 160°C for 0 1 mm and 
programmed to increase at a rate of 200°C/min to a final temperature of 225°C, which
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was held for 15 mm The detector temperature was 250°C The column oven was held 
at an initial temperature of 80°C for 8 mm and then programmed to increase at a rate 
of 8 5°C/min to a final temperature of 200°C, which was held for 77 min Data were 
recorded and analysed using a Mimchrom PC system (VG Data Systems, Cheshire, 
UK) CLA isomers were identified by retention time with reference to CLA standards
4.2.5 Fatty Acid Analysis of Feed
Oil was extracted from Pura 42™ and pasture using the Folch wash method (Christie, 
1989) A volume of 10 ml of methanol were added to 4 g Pura 42™ and vortexed for 1 
mm To this mixture was added 20 ml chloroform followed by vortexmg for 2 mm 
The mixture was filtered, followed by resuspension of the solid residue in 30 ml 
chloroform-methanol (2 1 v/v) and vortexmg for 3 mm The mixture was again filtered 
and the residue washed with 20 ml chloroform, vortexed for 1 mm, filtered and washed 
with 10 ml methanol, and again vortexed for 1 mm and filtered The filtrates from each 
step were combined A volume equal to 0 25 of the total volume of the filtrates was 
added to the filtrate m the form of 0 1 M potassium chloride in water The solution was 
shaken vigorously and centrifuged at 1,000 x g for 5 mm The upper layer was 
removed A volume equal to 0 25 of the volume of the lower layer was added in the 
form of water-methanol (11 v/v) The solution was centrifuged at 1,000 x g for 5 mm 
The bottom layer, containing purified lipids, was carefully removed and concentrated 
using rotary evaporation The fat was resuspended in hexane followed by drying with 
nitrogen gas and stored for methylation Methylation and GC analysis were performed 
as for milk fat samples using acid-catalysed methylation
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Blood samples were taken from coccygeal vessels into 7 ml hepanmsed vacutainers 
once after the morning milking m the 8th week of the experiment Plasma was prepared 
by centrifugation at 800 x g for 10 mm at 4°C and analysed for the following p- 
hydroxybutyrate (BHB), glucose, protein, urea, cholesterol, tngylcendedes and non- 
estenfied fatty acids (NEFA) usmg Cobas Mira biochemical Analyzer (Roche 
Diagnostics, Basel, Switzerland)
4.2 7 Statistical Analysis
Statistical procedures were carried out using SAS (SAS Institute, 1991), however 
correlations were earned out usmg MS Excel, 1997 The mean values for the 
experimental penod for milk, fat, protein and lactose yields and milk fat, protein and 
lactose concentrations were analysed as a randomised block design The model used 
for these analyses had terms for block (CLA group and supplementation), pre- 
expenmental data where appropnate and the interactions between CLA group and 
supplementation treatment The fatty acid content (at selection, day 0 and day 8) of the 
milk and the blood metabolite data were analysed as a randomised block and the model 
used had terms for block, CLA group (high or low) and supplementation treatment 
(none vs supplementation) Differences between treatments were tested for 
significance using student’s t test
4.2.6 Blood Analysis
116
Compositional analysis of pasture demonstrated that DM was 908 g/kg DM compared 
with 935 g/kg (DM) for the Pura 42™ supplement (Table 4.3) Fatty acid analysis 
demonstrated that the rapeseed supplement, Pura 42™ had a typical fatty acid profile 
for rapeseed (Lawless, et a l , 1998) Oleic acid was the predominant fatty acid at a 
concentration of 56% FAME, followed by LA at a concentration of 23% FAME The 
other fatty acids, palmitic acid, steanc acid, arachidomc acid and lmolemc acid were 
present at lower concentrations (Table 4.3)
4.3 Results
4.3.1 Feed Analysis
Table 4 3  Chemical composition of pasture and rapeseed supplement
Component Pasture Pura 42™
Dry matter (DM), g/kg 908 935
Ash, g/kg DM 84 51
Crude protein, g/kg DM 168 218
Orgamc matter digestibility
(OMD), g/kg DM 800 -
Fatty acids (% FAME)
C14 0 mynstic acid 0 8 -
C16 0 palmitic acid 12 4 6 7
C l8 0 stearic acid 1 9 19
C l8 1 c9 oleic acid 2 6 56 3
C18 2 linoleic acid 109 22 9
C l8 3 lmolemc acid 63 8 89
C20 4 arachadomc acid - 05
Analysis of pasture produced a typical fatty acid profile for pasture (Table 4 3) 
(Dhiman, et a l , 1995), being nch m lmolemc acid (64% FAME) with smaller 
quantities of linoleic (11% FAME) and palmitic acid (12% FAME) present Also 
present were mynstic acid, steanc acid and oleic acid at lower concentrations
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Production and composition data are presented m Table 4 4 On average, milk yield 
was significantly (POOOl) increased from 17 1 kg to 20 5 kg due to rapeseed 
supplementation Supplementation also led to significant increases in milk fat yield 
(12% increase), protein yield (19% increase) and lactose yield (21% increase) (Table 
4.4) However, the fat content was significantly reduced with rapeseed 
supplementation from 41 2 to 38 8 g/kg Supplementation had no significant effect on 
protein or lactose content
4.3,2 Effect of Supplementation on Milk Composition
T a b le  4 4 Average effect o f CLA content and supplementation on milk composition
Blood Component ________ CLA Content_________  Supplementation
Low High SEM p-value None +3 5kg SEM P-value
Milk Yield 18 8 18 7 0 58 NS 17 1 20 5 0 55 ***
Fat Yield 0 74 0 74 0 02 NS 0 70 0 78 0 02 *
Protein Yield 0 66 0 67 0 02 NS 0 61 0 73 0 02 ***
Lactose Yield 0 85 0 87 0 03 NS 0 78 0 94 0 03 ***
Fat (g/kg) 39 8 40 2 0 69 NS 412 38 8 0 66 *
Protein (g/kg) 36 0 36 5 0 32 NS 36 3 36 3 031 NS
Lactose (g/kg) 45 3 46 3 0 29 * 45 6 46 0 0 26 NS
NS = not statistically significant
* P<0 05 
*** P<0 001
4.3 3 Relationship Between CLA Content and Milk Composition
Comparison of the high and low CLA producing cows showed that lactose content was 
significantly (P<0 05) higher in high CLA producing cows (46 3 g/kg) compared with 
that of low CLA producmg cows (45 3 g/kg) There were no significant differences for 
the other parameters measured due to CLA content of milk fat (Table 4 4)
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It was found that the rapeseed supplementation significantly (P<0 01) reduced NEFA 
by 34% Supplementation significantly (P<0 05) increased blood protein by 3 5% and 
blood cholesterol (P<0 001) by 44% The supplement had no significant effect on 
blood glucose, BHB, urea, or triglycerides (Table 4 5)
4 3 4 Effect of Supplementation on Blood Components
Table 4 5 Effect o f supplementation on blood components
Blood Component CLA Content Supplementation
Low High P-value None +3 5 kg p-value
Glucose, mmol/L 4 18 4 47 *** 4 27 4 38 NS
NEFA, mmol/L 0 205 0 141 * 0 209 0 137 **
BHB, mmol/L 0 389 0 382 NS 0 347 0 424 NS
Protein, g/L 85 13 84 66 NS 83 45 86 34 *
Urea, mmol/L 5 88 5 89 NS 5 85 5 92 NS
Triglycerides, mmol/L 0 216 0 246 NS 0 223 0 239 NS
Cholesterol 5 01 4 87 NS 4 06 5 83 ***
NS = not statistically significant 
* P<0 05 
**P<0 01 
***P<0 001
4.3 5 Blood Components in Cows Selected for High and Low CLA Groups 
Of the blood components analysed, glucose and NEFA differed significantly between 
the high and low CLA producing cows (Table 4.5) Glucose was higher (P<0 001) in 
the blood of the high CLA group (4 47 mmol/L) compared with that of the low CLA 
group (4 18 mmol/L), whereas NEFA were lower (P<0 05) in the high CLA group 
(0 141) compared with the low group (0 205) The other blood components (BHB, 
protein, urea, triglycerides and cholesterol) analysed were not significantly different in 
low CLA-producmg cows compared with high CLA-producing cows
4.3.6 Effect of Supplementation on Fatty Acid Composition of Milk Fat
When comparing milk of supplemented cows with that of control cows (Figure 4 3) 
there was a notable difference m the concentration of a number of the milk fatty acids
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after 8 days of supplementation In general, the Pura 42™ supplemented diet led to a 
decrease in the saturated fatty acids and increases m unsaturated fatty acids in the milk 
fat Palmitic acid (C l6 0) was significantly reduced (P<0 001) by 29% due to rapeseed 
supplementation, whereas oleic acid (C l8 1 c9) was significantly increased (P<0 01) 
by 24% due to the supplemented diet LA (Cl 8 2) was also significantly higher 
(P<0 001) (by 39%) in supplemented cows Linolemc acid (C l8 3) was significantly 
lower (P<0 05) in the milk of supplemented cows (3 7 mg/g fat) compared with control 
milk (4 4 mg/g fat) Surprisingly, rapeseed supplementation had no significant effect 
on c9, t\ 1 CLA, the concentration being 8 6 mg/g fat in the control group compared 
with 9 2 mg/g fat in the supplemented group On the other hand, YA was significantly 
increased (P<0 01) by 22% after rapeseed supplementation from 20 to 25 mg/g fat 
However ¿10, c\2  CLA was significantly reduced (P<0 001) from 0 51 mg/g fat to 
0 33 mg/g fat due to rapeseed supplementation Elaidic acid (C l8 1 t9) was 
significantly higher (P<0 001) m the milk fat of supplemented cows (5 47 mg/g fat) 
compared with control cows (19 mg/g fat), an increase of 188% A significant 
(P<0 05) 10% increase in the concentration of Cl 8 0 (stearic acid) was observed m the 
milk fat of cows on the supplemented treatment Although concentrations of C4 0 and 
C6 0 were not significantly affected by the rapeseed supplement, concentrations of 
other short to medium chain fatty acids (C8 0 to C16 1) were reduced due to rapeseed 
supplementation, whereas concentrations of long chain fatty acids in milk fat were 
increased with the exception of ¿10, cl2 CLA, c9, ¿11 CLA and linolemc acid (C18 3)
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Figure 4.3 Effect o f 8 days rapeseed supplementation on fatty acid profile o f milk fat. Values shown are mean 
values o f individual cows
* P<0.05 
**P<0.01 
*** P<0.001
4.3.7 Relationship Between CLA Content and Fatty Acid Composition of Milk 
Fat
There were a number of significant differences between the fatty acid profiles of the 
high and low CLA treatment groups after 8 days supplementation (Figure 4.4).
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Most of the fatty acid concentrations were higher in the milk of the low CLA 
producing cows (Figure 4 4) The concentrations of C4 0 C6 0, C8 0, CIO 0, C12 0, 
C14 0, C14 1, C16 0, C16 15 C18 0, C18 1 c9y C18 2, and C18 3 were significantly 
higher in the milk fat of low CLA producing cows There was no significant difference 
in the concentrations of C14 1, C l8 1 (9, Cl 8 1 ¿1 1, c9, ¿11 CLA and ¿10, c l2 CLA in 
the milk fat obtained from the two groups
Figure 4 4 Fatty acid profile o f milk fat from cows selected for high and low CLA groups regardless o f  diet 
after 8 days supplementation
* P<0 05 
**p<0 01 
*** P<0 001
1 2 2
4 3.8 Relationship between Dietary Supplementation and Milk Fat CL A over the 
First Ten Days of the Trial
Figure 4 5 presents the c9, 111 CLA content of the composites of each of the four
treatment groups collected over the first ten days of the trial Surprisingly, there was no
significant difference due to rapeseed supplementation m c9, t\ 1 CLA content of the
milk fat from the low CLA unsupplemented group and the low CLA supplement group
(Figure 4.5) This was also observed in the two high CLA groups Milk fat CLA
concentrations did not increase in a consistent way on any of the treatment groups and
therefore, the time required to maximally ennch milk fat with CLA could not be
determined
D ajs
Figure 4 5 c9y t\  1 CLA content o f milk fat in composite samples over 10 days
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When companng the differences between the c9,111 CLA content of the high and low 
CLA producing cows on the unsupplemented diet it was found that the c9, t l  1 CLA 
content m the high CLA control group composite was significantly higher (P<0 01) 
than that of the low CLA control group by 13% at day 0 The c9, t\ 1 CLA content of 
milk fat from the high CLA unsupplemented group was again significantly higher at 
day 2 (P<0 001) by 54%, day 5 (P<0 05) by 68%, and day 6 (P<0 05) by 70% 
compared with that of the low CLA unsupplemented group Similar observations were 
made when companng the c9, t i l  CLA content of the two supplemented groups c9, 
t l  1 CLA was significantly higher in milk from the high CLA supplemented group at 
day 0 (P<0 05) by 24%, day 1 (P<0 05) by 92%, day 5 (P<0 01) by 62%, day 6 
(P<0 05) by 54% and day 9 (P<0 05) by 55% compared with that of the low CLA 
supplemented group However, the four composite groups appear to follow the same 
pattern of increases and decreases m c9, t i l  CLA after 1 day of supplementary 
treatment It was noted that there was no significant difference m the c9, t l  1 CLA 
content of composites from control groups compared with supplemented groups at 8 
days, the day on which individual samples were taken and in which no significant 
changes m c99 t l  1 CLA content were observed
4 3 9 Changes in CLA Content from Selection to Day 0 of Rapeseed 
Supplementation
The correlation (r = 0 0435) between the CLA concentrations in samples taken dunng 
the selection process and that of samples taken at day 0 was very weak (Figure 4.6) 
This indicates that there were large changes in the CLA content of the milk of 
individual cows over the time period between collection of these two sets of milk 
samples (20 days)
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Figure 4 6 Correlation between CLA concentrations in milk fat used for selection process and 
concentrations in milk fat at day 0 of the feeding tnal (y = 0 1238x + 9 2589) (MS 
Excel 1997)
4 3.10 Relationship Between Vaccenic Acid and c9, t i l  CLA 
Figure 4 7 presents the correlation between c9, t\ 1 CLA and VA from the time of 
selection to 8 days supplementation (Figure 4 7 A), the day on which rapeseed 
supplementation began -  day 0 (Figure 4.7B) and after 8 days of rapeseed 
supplementation (Figure 4.7C) Figure 4.7B shows that a strong correlation (r = 
0 8685) existed between the concentration of c9, t l  1 CLA and VA The relationship 
between c9, t \  1 CLA isomer and VA in the milk fat was still present at day 0 -  the day 
on which rapeseed supplementation commenced, but pnor to supplementation 
However, after 8 days supplementation the correlation (r = 0 0281) between c9, 111 
CLA and VA was very weak (Figure 4.7C)
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Figure 4 7 Correlation between c9, t\  1 CLA and VA at different time points (A) Correlation between 
c9, i l l  CLA and VA values in milk fat at selection (y = 2 0829x + 6 0943, r=0 8685) (B) 
Correlation between c9 , /1 1 CLA and VA values in milk fat at 0 days supplementation (y = 
2 2673x + 3 2046, r=0 8481) (C) Correlation between c9, i l l  CLA and VA values m milk 
fat after 8 days supplementation (y = 0 8309x + 32 056, i=0 0281) (MS Excel 1997)
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Figure 4 8 Correlations between CLA and vaccemc acid in each of the 4 treatment groups after 8 days 
supplementation (A) Low CLA Control Group, (B) Low CLA Supplement Group, (C) High 
CLA Control Group, (D) High CLA Supplement Group
Figure 4.8 shows the correlation between CLA and VA in milk fat obtained from each 
of the treatment groups after 8 days of the trial There was a very weak correlation 
between VA and c9, t i l  CLA in the milk of both the low CLA producing control (r = 
0 0025) and supplemented group (r = 0 0067) (Figure 4.8A) Similarly there was a 
weak correlation between VA and c9, t\ 1 CLA m milk fat of the high CLA producing 
control (r = 0 0081) and supplemented (r = 0 0517) groups This suggests that VA was 
not converted to c99 t\ 1 CLA to the same extent observed at the time of selection 
Therefore it appears that the relationship between VA and c991\ 1 CLA observed at the 
time of selection no longer existed 8 days after the tnal began regardless of diet
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Figure 4.9 Changes in fatty acid content o f  milk o f low control (LC, low supplement (LS), high 
control (HC) and high supplement (HS) cows with time. |  Selection, D Day 0, |  8 Days. 
A = c9, t\ 1 CLA, B = oleic acid, C = vaccenic acid, D = elaidic acid and E = palmitic 
acid
Five fatty acids were chosen to represent the changes in fatty acid content from time of 
selection up to 8 days supplementation. These fatty acids were c9, t\ 1 CLA, oleic acid, 
VA, elaidic acid and palmitic acid. Fatty acid content at the time of selection (20 days 
prior to commencement of dietary supplementation) and at day 0 should remain quite 
similar, as there was no change in diet. However this was not so, with individual fatty 
acid content being lower at day 0 compared with samples taken at the time of selection
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-  with the exception of the low supplement cows where the concentration of the fatty 
acids present remamed similar between these two time points (Figure 4.9) After 8 
days supplementation, milk fat c9, tl 1 CLA was at its lowest of the three time points 
despite the supplementation of the diet with rapeseed
Oleic acid content was lower m milk taken from cows m the high control group after 8 
days compared to samples taken at selection and day 0 Concentrations of this fatty 
acid were similar in day 0 samples and after 8 days supplementation in the other three 
treatment groups
Vaccemc acid increased in the low control, high control and high supplement groups 
after 8 days supplementation Elaidic acid remained similar in control groups although 
it was slightly higher at selection However, m the supplemented groups elaidic acid 
increased greatly after 8 days Palmitic acid decreased at each time point for each of 
the treatment groups except the low control group which increased slightly after 8 
days
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Dietary supplementation with the aim of enhancing milk fat CLA has been well 
studied, therefore it is of interest to explore the manipulation of other factors which 
may further enhance CLA concentrations in milk fat One of the aims of this study was 
to determine if purposefully selecting cows with a natural ability to produce high 
concentrations of milk fat CLA together with supplementation of the diet with 
rapeseed would lead to further elevated concentrations of milk fat CLA
4 41 Effect of CLA Producing Ability on Fatty Acid Profile of Milk Fat
When comparing the effect of CLA producing ability of the cows, C4 0 C6 0, C8 0, 
CIO 0, C12 0, C14 0, C14 1, C16 0, C16 1, C18 0, C18 1 c9, C18 2, and C18 3 fatty 
acids were higher in the low CLA producing cows whereas there was no significant 
difference in concentrations of C14 1, C l8 1 t9, C18 1 i l l ,  c9, /II CLA and ¿10, cl2 
CLA between the two groups Despite little change in CLA concentrations of 
individual milk samples due to supplementation, analysis of composite samples of the 
four treatment groups collected over the first 10 days of the trial showed some 
significant differences in CLA concentrations between high and low CLA groups 
Composites of milk from the high CLA control group contained 13%, 54%, 68%, and 
70% more c9, t\ 1 CLA than composites of milk from the low CLA control group at 
days 0, 2, 5 and 6 respectively Similarly there were differences m the c9, 111 CLA 
content of milk from the high CLA supplemented group and the low CLA 
supplemented group Composites of milk from the high CLA supplemented group 
collected on days 0, 1, 5, 6 and 9 were 24%, 92%, 62%, 54% and 55% (respectively) 
higher than composites of milk from cows m the low CLA supplemented group 
collected on the same days
4.4 Discussion
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Due to the fact that CLA concentrations m the milk fat were not enhanced by rapeseed 
supplementation as expected, it is difficult to compare the influence which CLA 
producing ability has on the other fatty acids present in milk fat Some of the 
composites showed differences in CLA content between low CLA groups and likewise 
in high CLA groups, whereas no such differences were observed in individual cows 
However, there were no significant differences m CLA between composite groups on 
day 8 -  the time at which the individual samples were collected therefore, these two 
sets of data are not contradictory
Analysis of the fatty acid profile of milk fat suggests that an ability to produce high 
concentrations of CLA led to lower concentrations of other fatty acids However there 
were differences in the blood components of cows from the two groups Blood glucose 
levels were higher in the high CLA producing cows whereas NEFA were lower in this 
group compared to low CLA producing cows This suggests that the high CLA cows 
were m a better energy status than the low CLA cows
Why cows differ in their ability to produce CLA is unclear However, as endogenous 
synthesis is the primary source of milk fat CLA (reviewed m Gmnan and Bauman, 
1999) it is likely that variations m CLA producing ability is due to genetic variations 
regarding A9-desaturase Another possibility is differences m rummal enviromnent 
between individual cows, with the rumen of some cows supporting optimal CLA 
production compared with that of other cows (reviewed in Gnmari and Bauman, 
1999) However, in this study the CLA producing ability of the cows changed m the 2 
week period between time of selection and day 0 The reason for such a change is 
unclear It may be possible that A9-desaturase activity may have been inhibited or it is
131
more likely that the unusual weather conditions experienced throughout the trial may 
have interfered with the content and quality of the pasture eaten by the cows, 
interfering with CLA production This possibility is discussed below
4 4 2 Effect of Rapeseed Supplementation on CLA Content of Milk Fat
Despite the abundance of evidence regarding the positive relationship between plant 
oil supplementation and increase in milk fat CLA, no such relationship was observed 
in this study Five fatty acids that are known to change after rapeseed supplementation 
or were observed to change in this study were plotted against time to determine the 
presence of any pattern over time In general, these fatty acids decreased between 
selection and day 0 (prior to commencing supplementation) VA was seen to increase, 
however an increase was observed m milk from the low and high control groups which 
did not receive supplementation, suggesting changes in pasture as this was the only 
form of feed available to these cows An increase in elaidic acid was observed after 
supplementation of the diet with rapeseed, rather than an increase in c9, t11 CLA 
Unlike VA, increases m elaidic acid were only observed in the milk of supplemented 
cows Elaidic acid concentrations m milk fat have not been reported, although a review 
by Jensen (2002) states that other Cl 8 1 tram isomers constitute 3% of reported oleic 
acid concentrations Increases m milk fat elaidic acid due to rapeseed (rich m oleic 
acid) supplementation have not been reported previously with studies reporting 
increase in Cl 8 1 and not differentiating between the vanous isomers of this fatty acid 
(Murphy, et al , 1995, Lawless, et a l , 1998) Mosley, et al (2002) demonstrated that a 
culture of mixed gut microbes from the stomach of cattle had an ability to produce a 
variety of trans isomers, including elaidic acid, from oleic acid However, it was 
difficult to determine the percentage of this isomer formed from oleic acid as the oleic
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acid substrate was contaminated with elaidic acid Elaidic acid is also produced from 
LA biohydrogenation in the rumen in the same manner as VA (Kepler, et a l , 1966) In 
the present study it may be possible that elaidic acid was the dominant by-product of 
rummal biohydrogenation as opposed to VA, although the conditions required for this 
to occur are unclear As the majority of c9, i l l  CLA is produced endogenously from 
VA (Griinan, et a l , 2000), a lack of VA would in turn lead to reduced production of 
c9, t\ 1 CLA Van Soest, (1994) demonstrated that reducing rummal pH led to changes 
m bactenal populations and in turn, alterations in the pattern of fermentation end 
products Gninari, et al (1998a) demonstrated that conditions of decreased rummal pH 
due to feeding of a high-concentrate, low fibre diet led to the formation of ¿10, c l2 
CLA and in turn C l8 1 tlO Grnnan and Bauman (1999) have proposed that the 
activity of a c9, /10 isomerase can increase, resulting m the formation of 110, cl 2 CLA 
This theory is supported by a study by Gninari, et al (1999) in which a low fibre diet 
led to increased concentrations of the tlO, cl2 CLA isomer in milk fat Therefore, it 
may also be possible that an isomerase, leading to the formation of elaidic acid, can 
increase in activity It has been demonstrated that the presence of fatty acids such as 
elaidic acid are not responsive to diet, however in this study we observed an increase 
m elaidic acid only in the milk of cows on the supplemented diet Kalscheur, et a l , 
(1997) demonstrated that low rummal pH due to a high concentrate diet resulted in 
increased flow of total 18 1 -trans isomers to the duodenum
Fatty acids consistmg of up to 16 carbons were significantly lower in supplemented 
cows as previously demonstrated by Murphy, et al (1990) after 3 weeks 
supplementation However, LA content decreased in the milk of supplemented cows in 
the study by Murphy, et al (1990) whereas m the present study LA increased due to
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rapeseed supplementation, although the data in the present study were collected after a 
shorter supplementation period
The supplement used in the present study consisted primarily of rapeseed, a plant oil 
which has previously been demonstrated to enhance CLA concentrations in milk fat 
(Stanton, e t a l , 1997, Lawless, e t  a l , (1998) Both the supplement and pasture showed 
typical fatty acid profiles indicating that the fatty acid content of the diet was not a 
reason for the unusual results Murphy, e t  a l , (1990) demonstrated that milk yield and 
lactose yields were increased by supplementation with ground FFR in agreement with 
the results of the present study
CLA content of milk fat is known to vary with seasons (reviewed in Jensen, 2002) 
The period over which this feeding trial was undertaken had an unusual weather 
pattern for the time of year -  there was excessive rainfall over the summer months It 
may be possible that this would have affected the quality of the pasture and 
consequently the outcome of the experiment At the time of selection and day 0 of the 
trial, the VA and c 9 f t \  1 CLA content m milk fat were closely correlated (r =  0 85) 
However, after 8 days supplementation the strong correlation disappeared -  
correlations of these two fatty acids within each treatment group showed similar 
patterns after 8 days supplementation This suggests changes in the biohydrogenation 
process taking place m the rumen However, despite the close correlation between VA 
and c9, i l l  CLA at day 0 (r = 0 8481), unexpected reductions m c9, /11 CLA were 
observed at this time compared with that at time of selection It was observed that at 
day 0 milk fat VA was at its lowest concentration of the 3 time points, hence the 
correlation with the reduced concentration of c9, t\ 1 CLA observed at this time point
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It may be possible that at day 0 the rate of conversion of VA to c9, t i l  CLA by the 
action of A9-desaturase in the mammary gland was inhibited It may also be possible 
that at day 0 VA concentrations were reduced m turn leading to reduced concentrations 
of c9, 111 CLA produced both via rummal biohydrogenation and endogenous 
synthesis At 8 days VA concentrations had increased, but normal biosynthesis of c9, 
t i l  CLA had not had sufficient time to reach its optimum
There were no effects on blood glucose and urea as a result of dietary supplementation 
m the present study Previously, Lawless, et al (1998) demonstrated that glucose was 
reduced and urea increased in the blood of cows supplemented with rapeseed 
Alterations m blood urea concentrations are an indication of the protein content of the 
feed Although urea levels were not altered in this study, blood protein levels increased 
in cows on the supplemented diet Changes in blood glucose levels may occur when 
metabolism is altered, while no such changes due to rapeseed supplementation were 
observed in this study Of the other blood components analysed, cholesterol increased 
significantly, while NEFA decreased in cows fed rapeseed Changes in both of these 
components were expected as the dietary supplementation was primarily of a lipid 
nature
Many of the changes expected due to rapeseed supplementation were observed m this 
study, a decrease in short-cham fatty acids and an increase in long-cham fatty acids in 
particular oleic acid and steanc acid As expected VA increased with rapeseed 
supplementation but not to the extent expected A 22% increase in VA was observed 
after supplementation compared to a 42% increase in a study by Lawless, et al (1998) 
However, CLA concentrations were not altered
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There are many factors which influence CLA content of milk fat Therefore, it is 
difficult to determine the reason for the unexpected lack of elevation of c9, tl 1 CLA m 
milk fat due to rapeseed supplementation As the fatty acid composition of the 
supplement used is typical for rapeseed it may be possible that another component of 
the rapeseed supplement interfered with ruminal fermentation, altering the level of 
CLA produced The unexpected elevation of elaidic acid also suggests an interference 
with the fermentation process Although CLA concentrations were not increased due to 
rapeseed supplementation expected increases and decrease in the other major fatty 
acids present were observed, however not to the extent expected This suggests that 
ruminal biohydrogenation may have been slowed One possible reason for this may be 
the unusual weather conditions which prevailed during the penod of the feeding trial -  
May and June (2002) The rainfall for the month of May 2002 (126 mm) was over 
twice the average rainfall (59 mm) m May for the previous 11 years (Nash, J , personal 
communication) The rainfall in June was also higher than the average rainfall for that 
month (78 mm compared with 56 mm) The ramfall m July and August was lower than 
the average Such weather conditions could have led to changes in the pasture, 
suggested in the elevated concentrations of VA m control groups after 8 days of the 
trial despite no change m feeding regime
4 4.4 Summary
Cows were selected for their ability to produce high concentrations of milk fat CLA 
High CLA-producmg groups were put either on a control diet (pasture alone), or 
pasture supplemented with 3 5 kg rapeseed/day Low CLA-producmg groups were put 
either on a control diet (pasture alone) or pasture supplemented with 3 5 kg
4 4 3 Conclusion
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rapeseed/day Milk fat from these groups was then analysed to determine differences 
in CLA content between high and low CLA-producing groups over a 10 day penod 
There was no significant difference between high CLA-producing cows and low-CLA 
producing cows m the c9, t i l  CLA concentration of milk fat from individual cows 
after 8 days supplementation However when analysing the fatty acid content of 
composite samples taken over the first 10 days of the trial, it was found that milk fat of 
the high CLA control group contained 13% (day 0)9 54% (day 2), 68% (day 5) and 
70% (day 6) more c9, t i l  CLA compared with composites of the low CLA control 
group Similarity, the milk fat of composites of the high CLA supplemented group 
contained 24% (day 0), 92% (day 1), 62% (day 5), 54% (day 6) and 55% (day 9) more 
c9, tl 1 CLA than composites of the low CLA supplemented group This study yielded 
a number of unexpected findings There was no significant effect on c9, tl 1 CLA due 
to rapeseed supplementation over 8 days, although elaidic acid significantly increased 
(P<0 001) by 188% due to dietary rapeseed with a concentration of 5 47 mg/g fat in 
milk fat from the high CLA supplemented group compared with 1 9 mg/g fat in milk 
fat from the low CLA supplemented group A correlation between VA and c9, t i l  
CLA which existed at the time of selection no longer existed 8 days into the trial 
These data suggest that alterations in the quality of the pasture and/ or rate of 
biohydrogenation in the rumen during supplementation period may have interfered 
with CLA production
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CHAPTER 5
D I S C U S S I O N
In the modem world there is much emphasis on the importance of a healthy diet This 
is due to the fact that a number of human diseases such as cancer, coronary heart 
disease (CHD) and osteoporosis, have been attributed to an unbalanced diet It was 
once believed that milk and dairy products were undesirable in the human diet due to 
its fat content However, there is an increasing amount of evidence which suggests that 
milk contains components which impart beneficial health effects when consumed 
Such components include, calcium, vitamin A and D, (3-carotene, unsaturated fatty 
acids, n-3 fatty acids, phospholipids, sphingohpids, butyric acid, essential fatty acids 
and conjugated linoleic acid (CLA) (Boland, et al 2001)
Studies investigating the mechanisms by which CLA inhibits carcinogenesis are still 
ongoing One of the objectives of this study was to determine if CLA inhibited the 
activity of ras, an oncogene which is known to be involved in a number of human 
cancers such as prostate and colon cancer Although data regarding the effect of CLA 
on this mechanism is limited, previous studies have demonstrated conflicting results 
Ip, et al (1997) suggested that CLA inhibition of mammary cancer was independent of 
the presence or absence of mutated ras O’Shea (2000) found that CLA isomers 
inhibited PFTase (an enzyme necessary for activation of ras) activity in colon and 
mammary cancer cell lines Experiment 1 in this study suggested that the c9, tl 1 CLA 
isomer inhibited growth of SW480 cell growth by inhibition of the activation of ras 
and also by inhibition of expression of the ras gene As suggested previously, CLA 
isomers differentially modulate carcinogenesis (Palombo, et a l , 2002) and this was 
demonstrated m the present study The ¿10, c l2 CLA isomer inhibited membrane and 
total ras, however O’Shea (2000) demonstrated that this CLA isomer stimulated
5 Discussion
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PFTase activity by 66% compared with a control Therefore, unlike the c9, t\ 1 CL A 
isomer, the data suggest that the ¿10, c\2 CLA isomer inhibited ras gene expression, 
resulting in reduced levels of ras available for activation despite the increased 
production of PFTase These data also suggest that growth of SW480 cells is only 
partially controlled by famesylation It is of interest that the much less studied VA -  a 
CLA precursor -  also demonstrated an ability to inhibit ras The SW480 cell line has 
been shown to convert VA to c9, tl 1 CLA (Miller, et al 2003) It is clear that not only 
are there numerous mechanisms by which CLA inhibits cancer development (reviewed 
m Belury, 2002), but also each isomer of CLA is capable of actmg against cancer in 
both similar and different ways
In the second expenment of this study, the anticarcmogemc activity of oils produced 
by the fermentation of LA with 2 Bifidobacterium strains (B breve NCFB 2258 and B 
lactis Bbl2) was mvestigated Both strains have been shown previously to possess an 
ability to produce CLA (Coakley et a l , 2003) The study was inconclusive in that 
when SW480 cells were incubated with 84 fig/ml of each oil the growth inhibitory 
effect observed appeared to be due to the concentrations of the primary fatty acids 
present in the oils However when the concentration of the treatment was reduced to 33 
fig/ml the growth inhibitory effect of the oils did not mimic that of the fatty acids 
present As suggested m Chapter 3, another component may be present in the oils 
which is responsible for the growth inhibition observed at the reduced concentration 
The identity of this component requires further investigation The presence of an 
unidentified component m the oils fermented by B breve NCFB 2258 and B lactis 
Bbl2 could be explained by the possibility of the production of a fermentation product 
such as butyric acid (Hague, et a l , 1993) or vitamin K (reviewed by Cummings and
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Macfarlane, 1997) However the fact that the control oil (which was not fermented by 
any bacterial strain) also produced similar results is not so easy to explain One 
possibility is the differential anticancer activity between estenfied fatty acids and 
FFAs There is the potential to use these Bifidobacterium probiotic strains with the 
added value of proven anticancer activity due to an ability to produce CLA Another 
interesting finding from this study was the potent anti carcinogenic activity of the ¿9, 
t\ 1 CLA isomer The c9, tl 1 CLA isomer inhibited growth of the SW480 cells at a 
concentration of 10-20 p-g/ml after 4 days incubation, whereas the t9, i l l  CLA isomer 
inhibited growth of SW480 cells at a concentration of 1-10 jug/ml after 4 days 
incubation The anticarcinogemc activity of this CLA isomer has not been reported 
previously
With the large amount of interest associated with the potential use of CLA in the 
development of functional foods it is of great significance to enrich CLA 
concentrations in milk Of the many methods previously studied to enrich milk fat 
CLA, the previously proven CLA enhancing dietary supplement, rapeseed. was chosen 
for Experiment 3 The aim of this experiment was to determine if rapeseed 
supplementation of the diet of cows with an ability to produce high concentrations of 
CLA on pasture would further enhance milk fat CLA concentrations However, 
unexpectedly, c9, t\ 1 CLA was not enhanced by rapeseed supplementation, contrary to 
what has previously been observed by Lawless, et al (1998) and Stanton, et al (1997) 
Therefore it was not possible to determine if purposely selecting high CLA producing 
cows further enhanced milk fat CLA CLA concentrations had dropped prior to 
rapeseed supplementation suggesting that the lack of CLA enrichment was due to a 
factor other than the supplement One possibility is the unusual weather conditions
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experienced at the time of the feeding tnal Excessive rainfall may have interfered with 
the composition of the pasture -  rainfall for the month of May was over twice the 
average rainfall for that time of year Pasture has been shown to affect the fatty acid 
composition of milk by its fat content but also by its influence on the microbial 
environment m the rumen (Grnnari and Bauman, 1999) Therefore, it is possible that 
an imbalance m the rumen microbial environment led to inadequate production of 
CLA Analysis of milk samples collected later in the feeding tnal is required to obtain 
a fuller picture of the fatty acid profile of supplemented milk over time
Further study of CLA is necessary in many areas In terms of enrichment of CLA, 
numerous supplements have been investigated for their ability to enhance milk fat 
CLA However, as already mentioned the balance of rummal bactena also strongly 
influences CLA synthesis m the ruminant Manipulation of these microorganisms has 
been suggested by Boland, et aI (2001) in that reducing bactena responsible for the 
saturation of c9, 111 CLA and VA in the biohydrogenation of LA would lead to 
enhanced levels of the two fatty acids available for absorption Increased 
concentrations of absorbed c9, ¿11 CLA can be incorporated into milk fat whereas, 
increased concentrations of absorbed VA will lead to increased concentrations 
available for the activity of A9-desaturase and in turn synthesis of c9, ¿1 1 CLA The 
aim of Expenment 3 was to select cows with an ability to produce high concentrations 
of milk fat CLA This charactenstic is presumably due to genetic expression of high 
quantities of A9-desaturase -  the activity of which is responsible for the synthesis of 
the majority of c9, ¿11 CLA found in milk fat (reviewed in Gninan and Bauman, 
1999) In Expenment 3, at day 0 there was very little vanation m CLA concentration in 
milk fat compared with milk collected at selection compared to the variation at the
/  t
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time of selection Therefore, repeating this experiment when CLA m milk fat has 
returned to concentrations with normal variation may lead to more useful data In 
addition, investigation of the expression of A9-desaturase in relation to CLA synthesis 
would further develop the possibilities of enriching milk fat with CLA
The potential for CLA is immense Fish oil, which has also been implicated with 
beneficial health effects in humans, must be administered at a dietaiy concentration of 
10% (reviewed in Ip, et a l , 1994b) However, CLA has been shown to inhibit 
mammary tumours m rats at a concentration as low as 0 1% It is important to keep m 
mind the different effects which synthetically produced CLA may have on human 
diseases compared with naturally produced CLA It is clear that each CLA isomer has 
different effects and when combined with one or more of the other CLA isomers may 
have different effects than those observed when administered as a single isomer When 
used as a chemotherapeutic it is more achievable to administer CLA in the quantities 
and combmations required to obtain the necessary results However, when used m 
functional foods, the composition of CLA will be primarily c9, t\ 1 CLA with smaller 
quantities of other isomers present and may be m both estenfied and free form 
Therefore, it is important to develop the potentials for synthetically produced CLA and 
naturally occurring CLA separately In terms of functional foods, it may be more 
beneficial to investigate the effect of milk and dairy products high in CLA on humans 
In addition, foods rich in CLA are generally also high in fat Therefore, foods rich in 
CLA may not be attractive to those who wish to keep their fat intake to a minimum As 
fat tends to have negative health effects it is important that the food as a whole be 
investigated for its beneficial health effects Already, dairy products containing
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probiotic bacteria are popular Use of strains which can produce CLA in products 
already enriched in CLA would further enhance the marketability of such products
It is important that investigation of the anticancer mechanisms of CLA continues in 
order to determine which isomers are most effective and to determine if combining 
specific isomers of CLA is more effective than single isomers alone
With all the interest and potential of CLA it is possible that animal fats may become 
more desirable in the human diet, paving the way for the development of a much wider 
variety of daiiy products Not only will these products appeal to the health conscious, 
but such products can be developed to enhance the beneficial effects, for example, 
further enrichment with CLA using methods discussed throughout this thesis In 
addition, negative aspects can be mampulated and m turn reduced or removed 
completely in order to render the products more attractive Such development of dairy 
products will result in products with beneficial health effects which outweigh any 
negative health effects
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